angiotensin ii has been researched along with natriuretic peptide, brain in 227 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (1.76) | 18.7374 |
| 1990's | 39 (17.18) | 18.2507 |
| 2000's | 91 (40.09) | 29.6817 |
| 2010's | 84 (37.00) | 24.3611 |
| 2020's | 9 (3.96) | 2.80 |
| Authors | Studies |
|---|---|
| Horio, T; Kohno, M; Murakawa, K; Takeda, T; Yasunari, K; Yokokawa, K | 2 |
| Horio, T; Kohno, M; Kurihara, N; Takeda, T; Yokokawa, K | 1 |
| Coutie, WJ; Lang, CC; Motwani, JG; Rahman, AR; Struthers, AD | 1 |
| Fukui, T; Horio, T; Ikeda, M; Kohno, M; Kurihara, N; Takeda, T; Yasunari, K; Yokokawa, K | 1 |
| Horio, T; Kohno, M; Takeda, T | 1 |
| Antunes-Rodrigues, J; Fregoneze, JB; Gutkowska, J; St-Pierre, S | 1 |
| Hashiguchi, T; Higuchi, K; Kangawa, K; Matsuo, H; Minamino, N; Nawata, H; Ohashi, M | 1 |
| Imura, H; Itoh, H; Kangawa, K; Matsuo, H; Minamino, N; Nakao, K; Shirakami, G; Yamada, T | 2 |
| Itoh, H; Nakao, K | 1 |
| Adachi, S; Akimoto, H; Fujisaki, H; Hata, M; Hirata, Y; Hiroe, M; Ito, H; Lin, M; Marumo, F; Tanaka, M | 1 |
| Anand-Srivastava, MB; de Champlain, J; Savoie, P | 1 |
| Cargill, RI; Lipworth, BJ | 2 |
| Cargill, RI; Lipworth, BJ; Struthers, AD | 1 |
| Brewer, A; Holcberg, G; Kossenjans, W; Miodovnik, M; Myatt, L | 1 |
| Holcberg, G; Kossenjans, W; Miodovnik, M; Myatt, L; Rosenn, B | 1 |
| Hu, RM; Levin, ER; Nazario, B; Pedram, A; Prins, B | 1 |
| Cargill, RI; Coutie, WJ; Lipworth, BJ | 1 |
| Espiner, EA; Hunt, PJ; Nicholls, MG; Richards, AM; Yandle, TG | 2 |
| Levin, ER; Rubin, SA | 1 |
| Crozier, IG; Espiner, EA; Nicholls, MG; Richards, AM; Yandle, TG | 1 |
| Clarkson, PB; MacDonald, TM; MacFadyen, RJ; Pringle, SD; Wheeldon, NM | 1 |
| Leskinen, H; Ruskoaho, H; Vuolteenaho, O | 1 |
| Richards, AM | 1 |
| Arai, M; Iso, T; Kogure, K; Nagai, R; Suzuki, T; Wada, A | 1 |
| Harada, M; Igaki, T; Itoh, H; Kuwahara, K; Masuda, I; Miyamoto, Y; Nakagawa, O; Nakao, K; Ogawa, E; Ogawa, Y; Saito, Y; Tanaka, I; Yamashita, J; Yoshimasa, T | 1 |
| Fukai, D; Hisanaga, T; Kinoshita, M; Mabuchi, N; Maeda, K; Maeda, Y; Ohnishi, M; Tsutamoto, T; Wada, A | 1 |
| Harada, K; Kijima, K; Komuro, I; Kudoh, S; Matsubara, H; Murakami, K; Sugaya, T; Yazaki, Y; Zou, Y | 1 |
| Antos, CL; Grant, SR; Lu, JR; Markham, B; Molkentin, JD; Olson, EN; Richardson, J; Robbins, J | 1 |
| Hamanaka, I; Harada, M; Ishikawa, M; Itoh, H; Kajiyama, N; Kamitani, S; Kuwahara, K; Masuda, I; Miyamoto, Y; Nakagawa, O; Nakao, K; Ogawa, E; Saito, Y; Takahashi, N | 1 |
| Gardner, DG; Liang, F | 1 |
| Carstens, J; Jensen, KT; Pedersen, EB | 1 |
| Charles, CJ; Espiner, EA; Nicholls, MG; Rademaker, MT; Richards, AM | 1 |
| Fujii, M; Hayashi, M; Hisanaga, T; Kinoshita, M; Mabuchi, N; Maeda, K; Ohnishi, M; Sawaki, M; Tsutamoto, T; Wada, A | 1 |
| Aakvaag, A; Djøseland, O; Hall, C; Hystad, M; Karlberg, BE; Kjekshus, J; Klinge, R | 1 |
| Isoyama, S; Kagaya, Y; Namiuchi, S; Otani, H; Shirato, K; Tanikawa, T | 1 |
| Burrell, CJ; Knightingale, AK; Marshall, AJ | 1 |
| Fujii, M; Hayashi, M; Hisanaga, T; Horie, H; Kinoshita, M; Mabuchi, N; Maeda, K; Ohnishi, M; Sawaki, M; Sugimoto, Y; Tsutamoto, T; Wada, A | 1 |
| Cleland, JG; Cowburn, PJ; Dargie, HJ; Hillier, C; McGrath, JC; McMurray, JJ; Morton, JJ | 1 |
| Kawano, H; Kimura, S; Kitamura, H; Kunieda, Y; Masuda, H; Nakagawa, K; Nakagawa, M; Nishimura, H; Sugano, T; Tsuji, H; Yoshizumi, M | 1 |
| Emmertsen, K; Hansen, OK; Hjortdal, VE; Jensen, KT; Olsen, KH; Pedersen, EB; Ravn, HB; Stenbøg, EV; Sørensen, KE | 1 |
| Kohno, Y; Oana, S; Ohnuma, N; Tanabe, M; Terai, M | 1 |
| Burnett, JC; Chen, HH | 1 |
| Espiner, EA; Frampton, CM; Nicholls, MG; Powell, JD; Rademaker, MT; Richards, AM; Troughton, RW; Yandle, TG | 1 |
| Akao, M; Horie, M; Kouchi, I; Murakami, T; Otani, H; Sakurai, T; Sasayama, S; Takano, M | 1 |
| Beyersdorf, F; Breyer, T; Burkard, T; Dohrmann, U; Dragu, A; Füchtbauer, EM; Holubarsch, CJ; Radicke, D; Schmidt-Schweda, S; Wakili, R; Wiese, S | 1 |
| Bech, JN; Bentzen, H; Pedersen, EB; Pedersen, RS | 3 |
| Burnett , JC; Grande, JP; Hart, CY; Housmans, PR; Meyer, DM; Redfield, MM; Tazelaar, HD | 1 |
| Albåge, A; Bengtsson, L; Berglund, H; Kennebäck, G; Lindblom, D; van der Linden, J | 1 |
| Ikeda, U; Lee, RT; Ohki, R; Shimada, K; Yamamoto, K | 1 |
| Charles, CJ; Nicholls, MG; Rademaker, MT; Richards, AM | 1 |
| Ajani, U; Arnold, M; Glynn, R; Greaves, S; Hall, C; Harel, F; Hennekens, C; Pfeffer, M; Rouleau, JL; Sirois, P; Solomon, S; White, M | 1 |
| Hesse, B; Kjaer, A | 1 |
| Eskelinen, S; Luodonpää, M; Ruskoaho, H; Vuolteenaho, O | 1 |
| Charles, CJ; Cooper, GJ; Coy, DH; Espiner, EA; Lewis, LK; Nicholls, MG; Rademaker, MT; Richards, AM | 1 |
| Eskelinen, S; Kerkelä, R; Majalahti-Palviainen, T; Pikkarainen, S; Pöntinen, J; Ruskoaho, H; Tokola, H; Vuolteenaho, O | 1 |
| Földes, G; Hautala, N; Leskinen, H; Nemer, M; Ruskoaho, H; Suo, M; Szokodi, I; Tóth, M; Uusimaa, P; Vuolteenaho, O | 1 |
| Imaki, T; Naruse, M; Sato, A; Takagi, S; Takano, K; Tanabe, A; Tsuchiya, K | 1 |
| Bruni, F; Carerj, S; Luzza, F; Rizzo, F | 1 |
| Hamada, M; Hara, Y; Hiwada, K; Ohtsuka, T; Shigematsu, Y | 1 |
| Adachi, Y; Fukamizu, A; Garbers, DL; Harada, M; Izumi, T; Kawakami, R; Kishimoto, I; Kuwahara, K; Li, Y; Nakagawa, Y; Nakanishi, M; Nakao, K; Saito, Y; Takahashi, N; Tanimoto, K | 1 |
| Abraham, MR; Beck, KC; Johnson, BD; Joyner, MJ; Olson, LJ; Turner, ST | 1 |
| Bilezikian, JP; Furuse, Y; Hisatome, I; Igawa, O; Kato, M; Kinugasa, Y; Kinugawa, T; Ogino, K; Ogura, K; Osaki, S; Shigemasa, C; Shimoyama, M; Tomikura, Y; Uchida, K | 1 |
| Ahn, S; Duprez, D; Galanti, L; Gurné, O; Ketelslegers, JM; Robert, A; Rousseau, MF; Van Mieghem, W | 1 |
| Iwao, H; Izumi, Y; Kim, S; Nakamura, Y; Omura, T; Takeuchi, K; Yoshida, K; Yoshikawa, J; Yoshiyama, M | 1 |
| Dusting, GJ; Ritchie, RH; Rosenkranz, AC; Woods, RL | 1 |
| Harada, E; Harada, M; Ito, T; Kurihara, H; Mizuno, Y; Nakamura, S; Nakao, K; Nakayama, M; Ogawa, H; Saito, Y; Shimasaki, Y; Yamamuro, M; Yasue, H; Yoshimura, M | 1 |
| Bech, JN; Bentzen, H; Nyvad, O; Pedersen, EB; Pedersen, RS | 1 |
| Albåge, A; Berglund, H; Kennebäck, G; van der Linden, J | 1 |
| deChâtel, R; Földes, G; Ilves, M; Lakó-Futó, Z; Leskinen, H; Ruskoaho, H; Sármán, B; Skoumal, R; Szokodi, I; Tokola, H; Tóth, M; Vuolteenaho, O | 1 |
| Aikawa, J; Ebine, K; Fukazawa, M; Ishikawa, M; Kubota, T; Moroi, M; Namiki, A; Yamaguchi, T | 1 |
| Harada, M; Kawakami, R; Kishimoto, I; Kuwahara, K; Nakagawa, Y; Nakanishi, M; Nakao, K; Ogawa, Y; Saito, Y; Takahashi, N | 1 |
| Charles, CJ; Espiner, EA; Frampton, CM; Nicholls, MG; Rademaker, MT; Richards, AM | 1 |
| Ebihara, A; Hirata, Y; Iimuro, S; Iwata, H; Kangawa, K; Nagai, R; Niu, P; Shindo, T; Suematsu, Y; Takeda, N; Zhang, Y | 1 |
| Bentzen, H; Nyvad, O; Pedersen, EB; Pedersen, RS | 1 |
| Anzai, T; Hashimoto, K; Himeno, H; Imai, K; Kawana, M; Kitakaze, M; Koretsune, Y; Maruyama, S; Masaoka, Y; Matsubara, H; Matsuoka, T; Miyao, Y; Miyatake, K; Miyauchi, T; Nakamura, Y; Nomura, F; Okamoto, H; Ozono, K; Sekiya, M; Shinohara, H; Shintani, U; Shiraki, T; Takaoka, H; Tsutamoto, T; Yasumura, Y; Yokoya, K; Yokoyama, H | 1 |
| Roig Minguell, E | 1 |
| Foldes, G; Lako-Futo, Z; Ruskoaho, H; Ruzicska, E; Sarman, B; Somogyi, A; Szenasi, G; Toth, M; Tulassay, Z; Wellmann, J | 1 |
| Dor, V | 1 |
| Doi, K; Francis, GS; Fukamachi, K; Hail, MD; Hoercher, KJ; McCarthy, PM; Ootaki, Y; Schenk, S; Starling, RC; Young, JB | 1 |
| Egashira, K; Hiasa, K; Ishibashi, M; Takeshita, A; Tan, C; Zhao, Q | 1 |
| Fujita, M; Hirata, A; Hori, M; Kitakaze, M; Liao, Y; Minamino, T; Nagamachi, Y; Nakatani, T; Ogawa, S; Okada, K; Ozawa, K; Takashima, S; Tomoike, H; Tsukamoto, O; Tsukamoto, Y; Yutani, C | 1 |
| Burkhoff, D; Dickstein, M; Gu, A; He, KL; Maurer, M; Sabbah, HN; Wang, J; Wei, CM; Yi, GH | 1 |
| Ogawa, H; Yoshimura, M | 1 |
| Fujiwara, H; Nishigaki, K | 1 |
| Berezin, AE | 1 |
| Bech, JN; Pedersen, EB; Starklint, J | 1 |
| Koda, M; Ogawa, R; Sakamoto, A | 1 |
| Backes, RJ; Bailey, KR; Burnett, JC; Frantz, RP; Grill, D; Hanna, RD; Heublein, D; Mookadam, F; Moualla, SK; Nelson, SM; Nobrega, TP; Olson, LJ | 1 |
| Asai, T; Fujita, H; Kanmatsuse, K; Kushiro, T | 1 |
| Clarke, E; Coombes, E; Dawes, M; Gosling, O; Martin, M; Smith, A | 1 |
| Carsia, RV; John-Alder, HB | 1 |
| Chan, KL; Dore, A; Ducharme, A; Houde, C; Juneau, M; Khairy, P; Marcotte, F; Mercier, LA | 1 |
| Iwao, H; Izumi, Y; Izumiya, Y; Kim-Mitsuyama, S; Namba, M; Wake, R; Yoshida, K; Yoshiyama, M | 1 |
| Bel-Hadj, S; Calderone, A; Clement, R; Drapeau, J; El-Helou, V; Gosselin, H; Villeneuve, L | 1 |
| Maeda, T; Makino, N; Oyama, J; Satoh, S; Sugano, M | 1 |
| Bech, JN; Jensen, P; Nyvad, O; Pedersen, EB; Starklint, J | 1 |
| Gao, LJ; Lin, XY; Xiao, LZ; Zhang, HF | 1 |
| Richards, AM; Stewart, RA; Wasywich, CA; Webster, MW | 1 |
| Abe, Y; Guo, P; Ishizawa, M; Kimura, S; Kohno, M; Miyatake, A; Mizushige, K; Murakami, K; Nagai, Y; Namba, T; Nishiyama, A; Noma, T; Ohmori, K; Rahman, M | 1 |
| Hirata, A; Igarashi, M; Kadomoto, Y; Tominaga, M | 1 |
| Date, T; Kawai, M; Mochizuki, S; Seki, S; Shimizu, M; Taniguchi, I; Taniguchi, M; Yoshida, S | 1 |
| Cameron, VA; Collins, RP; Frampton, CM; Palmer, BR; Pilbrow, AP; Richards, AM; Skelton, L; Troughton, RW; Yandle, TG | 1 |
| Gibbons, RJ; Johnson, BD; O'Malley, K; Olson, T; Somers, VK; Wolk, R | 1 |
| Hatano, M; Kinugawa, K; Kohmoto, O; Nagai, R; Takahashi, T; Usui, S; Yao, A | 1 |
| Bahlmann, L; Heinze, H; Heringlake, M; Klaus, S; Pagel, H; Wagner, K; Wergeland, R; Will, B | 1 |
| Dai, M; He, JR; Wen, QX | 1 |
| Piuhola, J; Ruskoaho, H; Szokodi, I | 1 |
| Charles, CJ; Rademaker, MT; Richards, AM | 1 |
| Sheng, L; Wu, SM; Yang, W; Ye, P | 1 |
| Li, HL; Li, TB; Liu, DP; She, ZG; Wang, AB; Wang, YG; Wei, YS; Yang, Q | 1 |
| Damm, DL; Kapoun, AM; Lam, A; Liang, F; O'Connell, M; Protter, AA; Quan, D | 1 |
| Chen, J; Fan, F; Han, L; Wang, S; Wang, X; Xie, X; Yan, J; Zhou, X | 1 |
| Fujii, M; Horie, M; Ohnishi, M; Sakai, H; Tanaka, T; Tsutamoto, T; Wada, A; Yamamoto, T | 1 |
| Hautala, N; Majalahti, T; Nemer, M; Paradis, P; Pikkarainen, S; Ruskoaho, H; Sármán, B; Suo-Palosaari, M; Tokola, H; Vuolteenaho, O; Wang, J | 1 |
| Bobillier, A; Gardner, R; Hillier, C; MacFadyen, R; Mann, J; McDonagh, T; McMurray, J; Murdoch, D; Seed, A | 1 |
| Bech, JN; Holm, C; Paulsen, L; Pedersen, EB; Starklint, J | 1 |
| Boomsma, F; Due-Andersen, R; Faber, J; Høi-Hansen, T; Kistorp, C; Olsen, NV; Pedersen-Bjergaard, U; Thorsteinsson, B | 1 |
| Davies, J; George, J; Morris, AD; Rajendra, NS; Struthers, AD; Swaminathan, K | 1 |
| Ehrlich, BE; Estrada, M; Giordano, FJ; Heidrich, FM; Huang, Y; Zhang, K | 1 |
| Hosoya, T; Ikeda, K; Ishikawa, M; Kawamura, M; Nakao, K; Otsubo, C; Tajima, N; Tojo, K; Tokudome, G; Udagawa, T | 1 |
| Bailey, KR; Boerrigter, G; Burnett, JC; Cataliotti, A; Chen, HH; Costello-Boerrigter, LC; James, KD; Malkar, NB; Martin, FL; Miller, MA; Polowy, K; Schirger, JA | 1 |
| Chen, S; Chen, Y; Dai, G; He, J; Huang, Y; Li, Z; Meng, R; Tang, L; Wang, L; Wu, Z; Xiao, P; Yao, F; Zhang, C | 1 |
| Bech, JN; Holst, LM; Paulsen, L; Pedersen, EB; Starklint, J | 1 |
| Gao, P; Huang, L; Li, W; Qian, DH | 1 |
| Lerch, R; Montessuit, C; Papageorgiou, I; Pellieux, C | 1 |
| Afzal, R; Floras, J; McKelvie, RS; Rouleau, JL; White, M; Yusuf, S | 1 |
| Majalahti, T; Ruskoaho, H; Tokola, H; Vuolteenaho, O | 1 |
| Baklanova, NA; Belenkov, IuN; Bolotina, MG; Lapina, IuV; Mareev, VIu; Masenko, VP; Narusov, OIu; Shestakova, MV | 1 |
| Fujii, M; Horie, M; Kawahara, C; Nishiyama, K; Tsutamoto, T; Yamaji, M; Yamamoto, T | 1 |
| Coffman, TM; Danser, AH; Gembardt, F; Heringer-Walther, S; Lassner, D; Le, TH; Schultheiss, HP; Sterner-Kock, A; Stijnen, T; van Esch, JH; Walther, T | 1 |
| Bech, JN; Lauridsen, TG; Nielsen, S; Pedersen, EB; Vase, H | 1 |
| Bech, JN; Lauridsen, TG; Pedersen, EB; Starklint, J; Vase, H | 1 |
| Anderson, WG; Cramp, RL; De Vries, I; Franklin, CE | 1 |
| Cai, Y; Ma, CG; Pan, CS; Qi, YF; Tang, CS; Yang, JH; Zhao, J | 1 |
| Kang, BY; Khan, JA; Mehta, JL; Ryu, S; Seung, KB; Shekhar, R | 1 |
| Fujiwara, M; Kinoshita, H; Kuwabara, Y; Kuwahara, K; Minami, T; Nakagawa, Y; Nakao, K; Usami, S; Yamada, Y | 1 |
| Bendtsen, F; Bie, P; Iversen, JS; Kjaer, A; Krag, A; Møller, S | 1 |
| Blaauw, E; Delhaas, T; Prinzen, FW; Snoeckx, LH; van Bilsen, M; van der Vusse, GJ; van Nieuwenhoven, FA; Willemsen, P | 1 |
| Aihara, K; Akaike, M; Hirata, Y; Ikeda, Y; Ise, T; Ishikawa, K; Iwase, T; Kato, S; Matsumoto, T; Sata, M; Sumitomo-Ueda, Y; Uemoto, R; Yagi, S; Yoshida, S | 1 |
| Czabanka, M; Eklund, L; Heljasvaara, R; Ilves, M; Janmey, P; Kerkelä, R; Leskinen, H; Peuhkurinen, K; Pihlajaniemi, T; Piuhola, J; Rasi, K; Ruskoaho, H; Rysä, J; Sormunen, R; Vajkoczy, P; Vuolteenaho, O | 1 |
| Fujita, H; Harasawa, S; Hirayama, A; Koike, M; Kushiro, T; Nagao, K; Okubo, K; Otsuka, Y | 1 |
| Han, B; He, Y; Ma, J; Pan, Y; Peng, T; Wang, Y; Wei, M; Xin, P; Zhu, W | 1 |
| Cai, H; Cao, SP; Gu, N; Qian, CF; Song, YH; Zhao, ZM | 1 |
| Cai, J; Li, X; Lu, X; Niu, K; Xin, W | 1 |
| Aro, J; Leskinen, H; Levijoki, J; Manninen, A; Moilanen, AM; Mustonen, E; Ruskoaho, H; Rysä, J; Serpi, R; Tokola, H; Vuolteenaho, O | 1 |
| Essick, EE; Ghobrial, J; Ohashi, K; Ouchi, N; Pimentel, DR; Sam, F; Shibata, R; Wilson, RM | 1 |
| Akiyama, K; Hata, M; Hirayama, A; Sezai, A; Shiono, M; Unosawa, S; Wakui, S; Yoshitake, I | 1 |
| Chang, L; Li, Y; Liu, J; Wang, M; Wang, Y; Yang, R; Zhang, H | 1 |
| Larsen, T; Lauridsen, TG; Matthesen, SK; Pedersen, EB; Vase, H | 1 |
| Bech, JN; Graffe, CC; Lauridsen, TG; Pedersen, EB | 1 |
| Chagas, C; Groban, L; Jessup, JA; Lin, MS; Lindsey, SH; Wang, H | 1 |
| Bech, JN; Graffe, CC; Lauridsen, TG; Pedersen, EB; Vase, H | 1 |
| Alexander, AE; Cao, AH; Irvine, JC; Kaye, DM; Kemp-Harper, BK; Lin, EQ; Love, JE; McMullen, JR; Patel, R; Ritchie, RH | 1 |
| Azibani, F; Chatziantoniou, C; Delcayre, C; Fazal, L; Samuel, JL | 1 |
| Lin, J; Lin, L; Peng, F; Tang, H | 1 |
| Chen, GP; Hu, SJ; Mou, Y; Yang, J; Ye, Y; Zhao, CZ; Zhu, HH | 1 |
| Akahashi, Y; Ambartsumian, N; Horie, T; Inuzuka, Y; Iwanaga, Y; Kato, T; Kawashima, T; Kimura, T; Kobuke, K; Koshimizu, TA; Lukanidin, E; Miyazaki, S; Morooka, H; Niizuma, S; Ono, K; Sheikh, SP; Shioi, T; Takase, T; Tamaki, Y | 1 |
| Gheissari, A; Merrikhi, A; Pirpiran, M; Sabri, M | 1 |
| Bu, L; Cheng, Z; Dong, D; Huang, T; Shen, B; Tu, Y; Wan, L; Zhao, D | 1 |
| Guo, XF; Jiang, H; Liu, GL; Lv, YJ; Qiao, Y; Ren, M; Wang, B; Yan, L; Zhang, JD | 1 |
| Chen, IJ; Dai, ZK; Hsu, JH; Liou, SF; Wu, BN; Wu, JR; Yang, SN; Yeh, JL | 1 |
| D'Angelo, A; Derosa, G; Fogari, R; Gualtierotti, R; Lazzari, P; Mugellini, A; Zoppi, A | 1 |
| Horiuchi, M; Kawajiri, M; Matsumoto, S; Mogi, M; Tsukuda, K; Yamada, T | 1 |
| Hu, W; Jiang, WB | 1 |
| Cheng, W; Ge, J; Hou, Y; Hu, J; Li, Y; Lv, P; Niu, C; Wang, F; Yan, Y; Yang, Z | 1 |
| Dai, Z; He, H; Huang, C; Meng, Y; Tang, Y; Wang, X; Xiao, J; Yu, S; Zhao, Q | 1 |
| Han, F; Lou, XF; Lu, YM; Sun, MM; Wang, P; Xie, YY; Zhang, BY; Zhang, C | 1 |
| Chen, S; Gardner, DG; Glenn, DJ; Ng, M; Ni, W; Watts, SW | 1 |
| Huang, X; Lin, Y; Qian, D; Tan, J; Wang, Y; Xia, J; Zhang, X | 1 |
| Ding, XQ; Fang, Y; Liu, ZH; Lv, WL; Shen, B; Teng, J; Tian, J; Yu, J; Zhang, XY; Zou, JZ | 1 |
| Shen, JH; Tan, JH; Wang, H; Xu, MC; Ying, H; Zhang, DF | 1 |
| Chen, J; Hu, YJ; Peng, DF; Tang, SY | 1 |
| Bian, ZY; Dai, J; Deng, W; Fang, Y; Li, FF; Tang, QZ; Wu, QQ; Xu, M; Yuan, Y; Zhang, JY; Zhou, H; Zong, J | 1 |
| Cha, SA; Gao, S; Kim, SH; Park, BM | 1 |
| Chen, S; Chen, Y; Dong, Y; He, J; Huang, H; Wu, L; Yao, F | 1 |
| Dai, Z; Huang, C; Huang, H; Tang, Y; Wang, X; Xiao, J; Yu, S; Zhao, Q | 1 |
| Guo, WX; Li, H; Li, YR; Lin, JM; Liu, Y; Wang, Y; Zhou, J | 1 |
| Ding, G; Huang, S; Jia, Z; Sun, Y; Zhang, A; Zhang, Y | 1 |
| Deng, L; Ding, F; Ding, Y; Shen, A; Yao, H; Ye, L; Zhang, L | 1 |
| Dong, X; Wang, X; Wei, L; Yin, Z; Zhang, L; Zhou, H | 1 |
| Baravoglia, CH; Bellavia, D; Bertani, T; Burnett, JC; Cataliotti, A; Clemenza, F; Gridelli, B; Luca, A; Scardulla, C; Traina, M | 1 |
| Fang, P; Geng, J; Li, Z; Liu, Q; Lu, D; Shan, Q; Wang, K; Wang, S; Wang, Y; Zhang, Q | 2 |
| Cao, TN; Cordero-Reyes, AM; Gupte, AA; Hamilton, DJ; Li, S; Smith, JA; Torre-Amione, G; Vedula, I; Youker, KA; Zhang, A | 1 |
| Cha, HN; Choi, JH; Heo, JY; Jang, BI; Kwon, WY; Lee, IK; Park, SY | 1 |
| Hirano, T; Hiromura, M; Kawashima, H; Kogure, M; Kohashi, K; Kushima, H; Mori, Y; Nakano, Y; Negoro, T; Sato, K; Shinmura, K; Terasaki, M; Tomoyasu, M; Wachi, T; Watanabe, R; Watanabe, T; Yamada, Y | 1 |
| Geng, J; Liu, Q; Lu, D; Shan, Q; Wang, K; Wang, S; Zhang, B; Zhang, Q | 1 |
| Ding, F; Gao, M; Lu, R; Lu, Y; Luo, S; Mu, W; Shu, Y; Sun, F; Xu, C; Yang, T; Zhang, G; Zhao, W; Zhou, X; Zhuang, Y | 1 |
| D'Elia, E; Emdin, M; Senni, M; Vergaro, G | 1 |
| Han, F; Li, J; Liu, M; Mao, C; Yang, P | 1 |
| Bao, Q; Chen, L; Li, J; Liu, X; Wu, S; Wu, W; Zhao, M | 1 |
| Okamura, K; Okuda, T; Shirai, K; Urata, H | 1 |
| Shen, Z; Wang, X; Yang, K; Zhang, Z | 1 |
| Chen, Y; Jiang, G; Lv, Q; Yuan, J; Zhu, J; Zou, Y | 1 |
| He, B; He, W; Hu, H; Jiang, H; Liu, S; Lu, Z; Luo, D; Ma, R; Qin, Z; Xie, J; Yu, X | 1 |
| Gao, L; Guo, S; Li, L; Li, R; Li, Y; Liu, Y; Niu, X; Wang, S; Yan, X; Yang, H; Yao, L; Zhang, Y; Zhao, X | 1 |
| Choi, SY; Jeong, MH; Jin, L; Kee, HJ; Kim, GR; Liu, B; Liu, CP; Piao, ZH; Ryu, Y; Sun, S | 1 |
| Cao, J; Li, Z; Liu, G; Wu, Y | 1 |
| Dai, F; Ma, S; Wang, Q; Yang, D; Yang, Y; Zhang, Y | 1 |
| Bu, X; Duan, X; He, Y; Hu, H; Liu, H; Ming, X; Sun, S; Wu, Q; Yan, F; Zhu, H | 1 |
| He, W; Jiang, H; Zhang, C | 1 |
| Gao, L; Kong, L; Shi, H; Tian, X; Wang, Z; Xiao, L; Zhao, L | 1 |
| Gong, H; Li, Y; Yang, C; Ye, Y; Yuan, J; Zhang, G; Zhang, X; Zou, Y | 1 |
| Cornelissen, G; El-Kilany, G; Fedacko, J; Hristova, K; Singh, RB | 1 |
| Cheng, M; Hu, S; Huang, CX; Jiang, H; Liu, BL; Tu, X; Wang, L; Wang, S; Wu, G | 1 |
| Chen, P; Deng, Y; Feng, H; Huang, L; Ouyang, W; Wang, J; Wu, J; Xian, J; Zhu, G | 1 |
| Ge, Z; Lin, J; Lin, Z; Liu, J; Wang, Y; Yuan, X; Zhang, C | 1 |
| Hu, Y; Li, J; Li, S; Li, Y; Ma, Y; Wen, J; Wu, J; Zhang, J; Zhang, L | 1 |
| Okamura, K; Okuda, T; Shirai, K; Takamiya, Y; Urata, H | 1 |
| Bi, HL; Cao, HJ; Han, L; Lai, S; Li, HH; Li, N; Wang, HX; Xie, X; Zhang, YL | 1 |
| Gao, Y; Ma, ZC; Tan, HL; Wang, J; Wang, NN; Wang, YG | 1 |
| Awwad, ZM; El-Ganainy, SO; El-Khatib, AS; ElMallah, AI; Khattab, MM; Khedr, SM | 1 |
| Gong, X; He, J; Li, Y; Lu, Y; Song, X | 1 |
| Chen, GH; Hu, J; Li, JL; Wang, HN; Xu, T; Yao, HQ | 1 |
| Chen, W; Chen, X; Li, W; Ma, L; Qiu, J; Shi, W; Tao, J; Wang, S; Zhou, N; Zou, M; Zou, R | 1 |
| Morishima, M; Ono, K | 1 |
| Ge, J; Li, R; Li, Y; Lin, L; Shi, Y | 1 |
| Cheng, Z; Feng, J; Gao, Y; Hou, L; Li, C; Wang, J; Zhou, J | 1 |
| Ji, M; Li, Y; Liu, Y; Ma, G | 1 |
| Chen, L; Li, Y; Liu, X; Wang, Y; Xing, Y; Zhang, G | 1 |
| Burnett, JC; Cannone, V; Chen, HH; Chen, Y; Ferrario, CM; Iyer, SR; Ma, X; Moroni, DG; Pan, S; Reginauld, SH; Sangaralingham, SJ; Yu, Y; Zhang, L; Zheng, Y | 1 |
10 review(s) available for angiotensin ii and natriuretic peptide, brain
| Article | Year |
|---|---|
The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Humans; Hypertension, Pulmonary; Hypoxia; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Pulmonary Circulation; Renin-Angiotensin System; Vascular Resistance; Vasoconstriction | 1995 |
The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiac Output, Low; Central Nervous System; Dogs; Humans; Hypertension; Male; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Proteins; Rats; Renin; Renin-Angiotensin System; Sheep | 1996 |
Natriuretic peptides in the pathophysiology of congestive heart failure.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Atrial Natriuretic Factor; Heart; Heart Failure; Humans; Natriuresis; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Prognosis; ROC Curve; Sensitivity and Specificity; Signal Transduction | 2000 |
Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Diagnosis, Differential; Endothelins; Heart Failure; Humans; Mortality; Natriuretic Peptide, Brain; Neurosecretory Systems; Prognosis; Renin-Angiotensin System; Tumor Necrosis Factor-alpha | 2001 |
[Pathophysiology of congestive heart failure].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Atrial Natriuretic Factor; Cytokines; Heart Failure; Humans; Natriuretic Peptide, Brain; Neurosecretory Systems; Neurotransmitter Agents; Prognosis; Rats; Renin-Angiotensin System; Risk Factors; Swine; Ventricular Dysfunction, Left | 2002 |
[Clinical use of markers of neurohormonal activation in heart failure].
Topics: Angiotensin II; Atrial Natriuretic Factor; Biomarkers; Endothelins; Heart Failure; Humans; Interleukin-6; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Renin; Tumor Necrosis Factor-alpha | 2004 |
[Natriuretic peptides in patients with ischemic heart disease].
Topics: Angina, Unstable; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Cytokines; Humans; Inflammation Mediators; Myocardial Infarction; Natriuretic Peptide, Brain; Ventricular Remodeling | 2004 |
[Natriuretic peptides and cardiomyopathy].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Biomarkers; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Humans; Natriuretic Peptide, Brain | 2004 |
Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction.
Topics: Adrenomedullin; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; beta-N-Acetyl-Galactosaminidase; Biomarkers; C-Reactive Protein; Cardio-Renal Syndrome; Catecholamines; Chromogranin A; Creatinine; Galectin 3; Glycopeptides; Growth Differentiation Factor 15; Heart Failure; Hepatitis A Virus Cellular Receptor 1; Humans; Interleukin-1; Interleukin-1 Receptor-Like 1 Protein; Interleukin-18; Interleukin-6; Lipocalin-2; MicroRNAs; Natriuretic Peptide, Brain; Peptide Fragments; Renin; Renin-Angiotensin System; Stroke Volume; Troponin; Troponin T; Tumor Necrosis Factor-alpha | 2017 |
Chronic heart failure: a disease of the brain.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Baroreflex; Brain; Cardiomegaly; Chronic Disease; Heart; Heart Failure; Humans; Inflammation; Natriuretic Peptide, Brain; Neuroimmunomodulation; Norepinephrine; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Renin-Angiotensin System; Sympathetic Nervous System; Vagus Nerve Stimulation | 2019 |
41 trial(s) available for angiotensin ii and natriuretic peptide, brain
| Article | Year |
|---|---|
Effect of angiotensin-converting enzyme inhibition on plasma brain natriuretic peptide levels in patients with heart failure.
Topics: Aged; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Captopril; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Radioimmunoassay; Single-Blind Method | 1992 |
Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans.
Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Hemodynamics; Humans; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Pulmonary Circulation; Vasodilator Agents | 1995 |
Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man.
Topics: Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Hemodynamics; Humans; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Renin-Angiotensin System | 1995 |
The effects of angiotensin II on circulating levels of natriuretic peptides.
Topics: Adult; Analysis of Variance; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Heart Rate; Humans; Infusions, Intravenous; Male; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Proteins; Renin-Angiotensin System; Vascular Resistance | 1994 |
Bioactivity and metabolism of C-type natriuretic peptide in normal man.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Creatinine; Cyclic GMP; Epinephrine; Hormones; Humans; Hydrocortisone; Infusions, Intravenous; Male; Metabolic Clearance Rate; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Norepinephrine; Potassium; Reference Values; Single-Blind Method; Sodium; Time Factors | 1994 |
Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension.
Topics: Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Double-Blind Method; Humans; Hypertension; Indans; Male; Methionine; Middle Aged; Natriuretic Peptide, Brain; Neprilysin; Nerve Tissue Proteins; Posture; Propionates; Time Factors | 1993 |
Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diastole; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Pulmonary Artery; Pulmonary Wedge Pressure; Single-Blind Method | 1996 |
Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Cardiotonic Agents; Deslanoside; Female; Guanosine Monophosphate; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Norepinephrine; Renin | 1997 |
Metabolism and action of urodilatin infusion in healthy volunteers.
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cross-Over Studies; Cyclic GMP; Diuretics; Double-Blind Method; Heart Rate; Hematocrit; Humans; Infusions, Intravenous; Kidney; Lithium; Male; Metabolic Clearance Rate; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Renin; Sodium | 1998 |
Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans.
Topics: Adult; Angiotensin II; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Female; Hematocrit; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Osmolar Concentration; Renin; Saline Solution, Hypertonic; Water Deprivation | 2001 |
Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction.
Topics: Angiotensin II; Atrial Natriuretic Factor; Biomarkers; Catecholamines; Dopamine; Double-Blind Method; Epinephrine; Epoprostenol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Norepinephrine; Ramipril; Stroke Volume; Ventricular Remodeling | 2001 |
Effect of an acute oral ibuprofen intake on urinary aquaporin-2 excretion in healthy humans.
Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Anti-Inflammatory Agents, Non-Steroidal; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Blood Pressure; Cross-Over Studies; Female; Heart Rate; Humans; Ibuprofen; Male; Middle Aged; Natriuretic Peptide, Brain; Nephrons; Osmolar Concentration; Reference Values; Renin; Sodium; Urine; Water | 2001 |
Beneficial effect of replacing of angiotensin-converting enzyme inhibitor with angiotensin II antagonist for heart failure patients.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure.
Topics: Angiotensin II; Atrial Natriuretic Factor; Echocardiography; Exercise Test; Exercise Tolerance; Female; Genotype; Heart Failure; Humans; Lung; Male; Middle Aged; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Pulmonary Gas Exchange; Regression Analysis; Respiratory Function Tests; Stroke Volume | 2002 |
Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy.
Topics: Aged; Aged, 80 and over; Angiotensin II; Atrial Natriuretic Factor; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Spironolactone; Treatment Outcome | 2002 |
Effect of an acute oral lithium intake on urinary Aquaporin-2 in healthy humans with and without simultaneous stimulation with hypertonic saline infusion.
Topics: Administration, Oral; Adult; Angiotensin II; Antimanic Agents; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Female; Heart Rate; Humans; Lithium Carbonate; Male; Middle Aged; Natriuretic Peptide, Brain; Osmolar Concentration; Radioimmunoassay; Renin; Saline Solution, Hypertonic; Sodium; Urine | 2003 |
Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bosentan; Cardiac Output; Cardiac Output, Low; Cardiac Pacing, Artificial; Cyclic GMP; Endothelin Receptor Antagonists; Endothelin-1; Female; Infusions, Parenteral; Losartan; Natriuretic Peptide, Brain; Renin; Sheep; Sulfonamides | 2004 |
Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Drug Synergism; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Failure; Heart Function Tests; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Receptors, Angiotensin; Renin; Tetrazoles; Valine; Valsartan | 2004 |
Effects of atrial natriuretic peptide at a low dose on water and electrolyte metabolism during general anesthesia.
Topics: Aged; Aldosterone; Anesthesia, General; Anesthetics, Inhalation; Angiotensin II; Atrial Natriuretic Factor; Double-Blind Method; Female; Gastrectomy; Hemodynamics; Hormones; Humans; Hydrocortisone; Infusions, Intravenous; Male; Methyl Ethers; Middle Aged; Natriuretic Peptide, Brain; Renin; Sevoflurane; Urodynamics; Vasopressins; Water-Electrolyte Balance | 2005 |
Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Atrial Natriuretic Factor; Biomarkers; Carbazoles; Carvedilol; Endothelin-1; Endothelins; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Propanolamines | 2005 |
Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cross-Over Studies; Double-Blind Method; Echocardiography, Transesophageal; Epinephrine; Exercise; Humans; Losartan; Natriuretic Peptide, Brain; Norepinephrine; Oxygen Consumption; Peptide Fragments; Transposition of Great Vessels; Treatment Outcome; Ventricular Dysfunction, Right | 2005 |
Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Aquaporin 2; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Cross-Over Studies; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Renin | 2006 |
[Effects of carvedilol on neurohormone and magnesium metabolism in patients with chronic heart failure].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Angiotensin II; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Magnesium; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Propanolamines | 2005 |
Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Proteinuria; Transforming Growth Factor beta | 2006 |
Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Spironolactone; Tetrazoles; Ventricular Remodeling | 2006 |
[Effects of xinshuai mistura on plasma angiotensin II, atrial natriuretic peptide and N terminal pro-brain natriuretic peptide in patients with heart failure].
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Captopril; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Phytotherapy; Single-Blind Method; Treatment Outcome | 2006 |
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.
Topics: Aged; Aldosterone; Amides; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Fumarates; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Ramipril; Renin; Statistics, Nonparametric; Treatment Outcome | 2007 |
Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
Topics: Adult; Angiotensin II; Arginine Vasopressin; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diuresis; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Tubules; Male; Natriuresis; Natriuretic Peptide, Brain; Pyrroles; Renal Plasma Flow | 2008 |
NT-pro-BNP during hypoglycemia and hypoxemia in normal subjects: impact of renin-angiotensin system activity.
Topics: Adult; Angiotensin II; Blood Glucose; Blood Pressure; Cross-Over Studies; Humans; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Insulin; Male; Natriuretic Peptide, Brain; Peptide Fragments; Reference Values; Renin; Renin-Angiotensin System | 2008 |
Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles.
Topics: Aged; Aldosterone; Angiotensin II; Blood Glucose; Blood Pressure; Body Mass Index; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Endothelium, Vascular; Female; Fibroblast Growth Factors; Glycated Hemoglobin; Humans; Hydrocortisone; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain | 2008 |
Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin-treated healthy men.
Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerular Filtration Rate; Heptanoic Acids; Humans; Kidney Function Tests; Lithium; Male; Natriuretic Peptide, Brain; Pyrroles; Renin; Sodium; Vasopressins | 2009 |
Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Double-Blind Method; Drug Therapy, Combination; Enalapril; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Peptide Fragments; Radionuclide Angiography; Stroke Volume; Tetrazoles; Treatment Outcome; Ventricular Function, Left | 2009 |
Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Male; Middle Aged; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Tetrazoles | 2010 |
Direct effect of methylprednisolone on renal sodium and water transport via the principal cells in the kidney.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Aquaporin 2; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Epithelial Sodium Channels; Female; Humans; Kidney; Male; Methylprednisolone; Middle Aged; Natriuretic Peptide, Brain; Pulse; Renin; Sodium | 2010 |
Protein-enriched diet increases water absorption via the aquaporin-2 water channels in healthy humans.
Topics: Absorption; Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Aquaporin 2; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Cyclic AMP; Dietary Proteins; Dinoprostone; Epithelial Sodium Channels; Female; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nephrons; Renin; Sodium; Vasopressins; Water; Young Adult | 2010 |
Myocardial protective effect of human atrial natriuretic Peptide in cardiac surgery. -hANP Shot” in clinical safety trial-.
Topics: Aged; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Cardiotonic Agents; Coronary Artery Bypass; Creatine Kinase, MB Form; Cyclic GMP; Dose-Response Relationship, Drug; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Heart Arrest, Induced; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Postoperative Complications; Renin; Troponin I | 2011 |
Effect of potassium supplementation on renal tubular function, ambulatory blood pressure and pulse wave velocity in healthy humans.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Aquaporin 2; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Cyclic AMP; Dietary Supplements; Endothelins; Epithelial Sodium Channels; Female; Glomerular Filtration Rate; Humans; Male; Natriuretic Peptide, Brain; Potassium; Renin; Sodium; Vascular Stiffness; Young Adult | 2012 |
Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Aquaporin 2; Atrial Natriuretic Factor; Chronic Disease; Cross-Over Studies; Cyclic AMP; Dinoprostone; Epithelial Sodium Channels; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Polycystic Kidney, Autosomal Dominant; Renin; Saline Solution, Hypertonic; Sodium; Vasopressins; Young Adult | 2012 |
Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Atrial Natriuretic Factor; Cross-Over Studies; Cyclic AMP; Dinoprostone; Epithelial Sodium Channels; Female; Glomerular Filtration Rate; Humans; Hypertension; Linear Models; Male; Middle Aged; Natriuretic Peptide, Brain; Osmolar Concentration; Renin; Sodium; Sodium, Dietary; Vasopressins | 2012 |
Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuria.
Topics: Adult; Aged; Albumins; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazolidines; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Ramipril; Treatment Outcome | 2013 |
Inappropriately elevated endothelin-1 plays a role in the pathogenesis of intradialytic hypertension.
Topics: Adrenomedullin; Adult; Aged; Aldosterone; Angiotensin II; Endothelin-1; Female; Humans; Hypertension; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; Norepinephrine; Peptidyl-Dipeptidase A; Renal Dialysis | 2015 |
176 other study(ies) available for angiotensin ii and natriuretic peptide, brain
| Article | Year |
|---|---|
Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin II in porcine aorta.
Topics: Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Endothelins; Endothelium, Vascular; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Radioimmunoassay; Swine | 1992 |
C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3',5'-monophosphate.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Chromatography, High Pressure Liquid; Cyclic GMP; Endothelins; Endothelium, Vascular; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Swine; Thrombin | 1992 |
Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Endothelins; Glomerular Mesangium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Nitroprusside; Protein Kinase C; Rats; Rats, Sprague-Dawley | 1992 |
Effects of arginine vasopressin, angiotensin II and endothelin-1 on the release of brain natriuretic peptide in vivo and in vitro.
Topics: Anesthesia; Angiotensin II; Animals; Animals, Newborn; Arginine Vasopressin; Blood Pressure; Brain Chemistry; Cells, Cultured; Chromatography, High Pressure Liquid; Endothelins; Heart Rate; Male; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred Strains | 1992 |
Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells.
Topics: Angiotensin II; Atrial Natriuretic Factor; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclic GMP; Endothelins; Endothelium, Vascular; Humans; Immunoassay; In Vitro Techniques; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Secretory Rate; Thrombin | 1991 |
Effect of brain natriuretic peptide on dehydration- or angiotensin II-induced water intake in rats.
Topics: Angiotensin II; Animals; Dehydration; Drinking; Injections, Intraventricular; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred Strains | 1989 |
Porcine brain natriuretic peptide, another modulator of bovine adrenocortical steroidogenesis.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Cattle; Cell Membrane; Cyclic GMP; Hydrocortisone; In Vitro Techniques; Kinetics; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface | 1988 |
Antidipsogenic action of a novel peptide, 'brain natriuretic peptide', in rats.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Drinking Behavior; Injections, Intraventricular; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Intracerebroventricular injection of brain natriuretic peptide inhibits vasopressin secretion in conscious rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Brain; Injections, Intraventricular; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred Strains | 1988 |
Antagonism between the vascular renin-angiotensin and natriuretic peptide systems in vascular remodelling.
Topics: Angiotensin II; Animals; Arteriosclerosis; Atrial Natriuretic Factor; Base Sequence; Cattle; Cell Division; Cells, Cultured; Endothelium, Vascular; Gene Expression Regulation; Guanylate Cyclase; Hypertension; Male; Molecular Sequence Data; Muscle, Smooth, Vascular; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Proteins; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Atrial Natriuretic Factor; Renin-Angiotensin System; RNA; Stimulation, Chemical | 1994 |
Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; DNA, Complementary; Endothelins; Fibroblasts; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Nitroprusside; Rats | 1995 |
C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors.
Topics: Adenylyl Cyclase Inhibitors; Angiotensin II; Animals; Atrial Natriuretic Factor; Cell Membrane; Guanine Nucleotides; Guanosine 5'-O-(3-Thiotriphosphate); Guanylate Cyclase; Isoproterenol; Kinetics; Myocardium; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Proteins; Rats; Receptors, Atrial Natriuretic Factor | 1995 |
The action of two natriuretic peptides (atrial natriuretic peptide and brain natriuretic peptide) in the human placental vasculature.
Topics: Angiotensin II; Arginine; Atrial Natriuretic Factor; Benzamidines; Blood Vessels; Dose-Response Relationship, Drug; Female; Humans; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Nitroarginine; Osmolar Concentration; Placenta; Pregnancy; Vasoconstriction | 1995 |
Interaction of angiotensin II and brain natriuretic peptide in the placentas of normal and diabetic women.
Topics: Adult; Analysis of Variance; Angiotensin II; Case-Control Studies; Drug Interactions; Female; Humans; In Vitro Techniques; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Placenta; Pregnancy; Pregnancy in Diabetics; Vasoconstriction | 1995 |
Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells.
Topics: Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Cattle; Cells, Cultured; Endothelins; Endothelium, Vascular; Gene Expression Regulation; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Protein Biosynthesis; Proteins; RNA, Messenger | 1995 |
Clinical review 53: The endocrinology of vasoactive peptides: synthesis to function.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Vessels; Endocrine Glands; Endothelins; Humans; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Peptide Biosynthesis; Peptides | 1994 |
Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
Topics: Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Guanylate Cyclase; Humans; Infusions, Intravenous; Male; Natriuresis; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Plasma Volume; Receptors, Atrial Natriuretic Factor; Time Factors | 1996 |
Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Function, Right; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Volume; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hemodynamics; Hormones; Imidazoles; Losartan; Male; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptides, Cyclic; Plasma Substitutes; Pressure; Protein Precursors; Rats; Rats, Sprague-Dawley; Sulfonamides; Tetrazoles | 1997 |
Humoral factor(s) produced by pressure overload enhance cardiac hypertrophy and natriuretic peptide expression.
Topics: Angiotensin II; Animals; Aortic Coarctation; Atrial Natriuretic Factor; Atrophy; Blood Pressure; Body Weight; Cardiomegaly; Endothelin-1; Heart Rate; Heart Transplantation; Hypertension; Male; Myosins; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred Lew; RNA, Messenger; Transcription, Genetic; Transplantation, Heterotopic; Transplantation, Isogeneic | 1997 |
Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cattle; Coculture Techniques; Culture Media, Conditioned; Endothelin Receptor Antagonists; Endothelin-1; Hypertrophy; Lipoproteins, LDL; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Paracrine Communication; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Endothelin; RNA, Messenger; Transforming Growth Factor beta; Ventricular Function | 1997 |
Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice.
Topics: Angiotensin II; Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Gene Expression; Genes, fos; Genes, jun; Hemodynamics; Infusions, Intravenous; Mice; Mice, Knockout; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Polymerase Chain Reaction; Transcription, Genetic; Ventricular Pressure | 1998 |
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Calcineurin; Cardiomegaly; Cell Nucleus; DNA-Binding Proteins; GATA4 Transcription Factor; Immunosuppressive Agents; Mice; Mice, Transgenic; Myocardium; Natriuretic Peptide, Brain; NFATC Transcription Factors; Nuclear Proteins; Phenylephrine; Promoter Regions, Genetic; Rats; Recombinant Fusion Proteins; Signal Transduction; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Zinc Fingers | 1998 |
Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Cell Communication; Cells, Cultured; Coculture Techniques; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Physical Stimulation; Rats; Tetrazoles | 1998 |
Autocrine/paracrine determinants of strain-activated brain natriuretic peptide gene expression in cultured cardiac myocytes.
Topics: Angiotensin II; Animals; Antibodies; Autocrine Communication; Cells, Cultured; Culture Media, Conditioned; Endothelin-1; Gene Expression Regulation; Genes, Reporter; Humans; Losartan; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Paracrine Communication; Peptides, Cyclic; Promoter Regions, Genetic; Rats; RNA, Messenger; Sprains and Strains; Transfection; Transforming Growth Factor beta; Ventricular Function | 1998 |
Chronic infusions of brain natriuretic peptide in conscious sheep: bioactivity at low physiological levels.
Topics: Analysis of Variance; Angiotensin II; Animals; Atrial Function, Right; Atrial Natriuretic Factor; Cardiac Output; Creatinine; Cyclic GMP; Female; Hemodynamics; Infusions, Intravenous; Natriuresis; Natriuretic Peptide, Brain; Potassium; Random Allocation; Sheep; Time Factors | 1998 |
Relationship between endothelin-1 extraction in the peripheral circulation and systemic vascular resistance in patients with severe congestive heart failure.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Endothelin-1; Female; Femoral Artery; Femoral Vein; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Pulmonary Wedge Pressure; Severity of Illness Index; Vascular Resistance | 1999 |
An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Biomarkers; Endothelin-1; Epinephrine; Female; Heart Failure; Male; Myocardium; Natriuretic Peptide, Brain; Norepinephrine; Pacemaker, Artificial; Protein Precursors; Renin; Swine | 1998 |
Concentrations of angiotensin II, endothelin-1, and BNP in the coronary sinus and ascending aorta of patients with heart disease.
Topics: Aged; Angiotensin II; Aorta; Biomarkers; Cardiac Catheterization; Coronary Vessels; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain | 1999 |
Anomalous origin of the left coronary artery from the pulmonary artery.
Topics: Angiotensin II; Biomarkers; Endothelin-1; Female; Heart Failure; Humans; Natriuretic Peptide, Brain | 1999 |
Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II; Biomarkers; Endothelin-1; Female; Humans; Incidence; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Proportional Hazards Models; Radioimmunoassay; Retrospective Studies; Severity of Illness Index; Stroke Volume; Survival Rate; Ventricular Dysfunction, Left; Ventricular Pressure | 1999 |
Structural and functional assessment of small arteries in patients with chronic heart failure.
Topics: Acetylcholine; Adult; Aged; Analysis of Variance; Angiotensin II; Arteries; Bradykinin; Case-Control Studies; Dose-Response Relationship, Drug; Endothelin-1; Epoprostenol; Female; Heart Failure; Humans; Male; Middle Aged; Muscle, Skeletal; Myography; Natriuretic Peptide, Brain; Nitroprusside; Norepinephrine; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells.
Topics: Angiotensin II; Animals; Blotting, Northern; Cells, Cultured; Culture Media, Conditioned; Cyclic GMP; Endothelium, Vascular; Gene Expression Regulation; Lipopolysaccharides; Lipoproteins; Male; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Second Messenger Systems; Thionucleotides; Thrombin; Thromboplastin; Tissue Plasminogen Activator | 1999 |
Neurohormonal activation late after cavopulmonary connection.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Child; Child, Preschool; Cross-Sectional Studies; Follow-Up Studies; Heart Bypass, Right; Heart Defects, Congenital; Hemodynamics; Hormones; Humans; Natriuretic Peptide, Brain; Neurosecretory Systems; Postoperative Period; Renin | 2000 |
Plasma brain natriuretic peptides and renal hypertension.
Topics: Adolescent; Angiotensin I; Angiotensin II; Atrophy; Blood Pressure; Child; Child, Preschool; Female; Heart Failure; Humans; Hypertension, Renal; Kidney; Male; Natriuretic Peptide, Brain; Neuroblastoma; Renin; Ventricular Function, Left | 2000 |
Beneficial renal and hemodynamic effects of omapatrilat in mild and severe heart failure.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Cardiovascular Agents; Cross-Over Studies; Cyclic GMP; Disease Models, Animal; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Injections, Intravenous; Kidney; Natriuretic Peptide, Brain; Pyridines; Renin; Sheep; Sodium; Thiazepines | 2000 |
Angiotensin II type 1 receptor blockade abolishes specific K(ATP)channel gene expression in rats with myocardial ischemia.
Topics: Angiotensin I; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, Northern; Blotting, Western; DNA, Complementary; Lisinopril; Male; Myocardial Ischemia; Myocardium; Natriuretic Peptide, Brain; Potassium Channels; Potassium Channels, Inwardly Rectifying; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System; RNA; RNA, Messenger; Tetrazoles; Time Factors; Up-Regulation | 2000 |
Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length.
Topics: Angiotensin II; Blotting, Northern; Cardiomegaly; Diastole; Heart Atria; Heart Ventricles; Humans; In Vitro Techniques; Isometric Contraction; Muscle Fibers, Skeletal; Myocardial Contraction; Myocardium; Natriuretic Peptide, Brain; RNA, Messenger; Stress, Mechanical | 2000 |
Load versus humoral activation in the genesis of early hypertensive heart disease.
Topics: Angiotensin II; Animals; Catecholamines; Diastole; Disease Models, Animal; Dogs; Endothelin-1; Heart Ventricles; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Kidney; Natriuretic Peptide, Brain; Propranolol; Renin; Systole; Ventricular Dysfunction, Left | 2001 |
Elevations in antidiuretic hormone and aldosterone as possible causes of fluid retention in the Maze procedure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Fibrillation; Atrial Natriuretic Factor; Coronary Artery Bypass; Female; Heart Atria; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Postoperative Complications; Vasopressins; Water-Electrolyte Balance | 2001 |
Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Biological Transport; Cardiomegaly; Cells, Cultured; Chromans; Heart; Leucine; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; Phenylephrine; Prostaglandin D2; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Stress, Mechanical; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2001 |
Comparative actions of adrenomedullin and nitroprusside: interactions with ANG II and norepinephrine.
Topics: Adrenomedullin; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Consciousness; Creatinine; Endothelins; Female; Heart Rate; Hemodynamics; Homeostasis; Natriuretic Peptide, Brain; Nitroprusside; Norepinephrine; Peptides; Potassium; Renin-Angiotensin System; Sheep | 2001 |
Effects of adrenomedullin on hypertrophic responses induced by angiotensin II, endothelin-1 and phenylephrine.
Topics: Adrenomedullin; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclic AMP; Cyclic GMP; Drug Interactions; Endothelin-1; Gene Expression; Heart; Heart Ventricles; In Vitro Techniques; Myocardium; Natriuretic Peptide, Brain; Peptides; Phenylephrine; Rats; Sarcomeres | 2001 |
Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
Topics: Adrenomedullin; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic AMP; Cyclic GMP; Dipeptides; Drug Synergism; Female; Heart Failure; Hemodynamics; Kidney; Natriuretic Peptide, Brain; Neprilysin; Peptides; Protease Inhibitors; Renin; Sheep; Vasodilator Agents | 2002 |
Decoy oligonucleotide characterization of GATA-4 transcription factor in hypertrophic agonist induced responses of cardiac myocytes.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Binding Sites; Cardiomegaly; DNA-Binding Proteins; Endothelin-1; GATA4 Transcription Factor; Gene Expression Regulation; Myocardium; Natriuretic Peptide, Brain; Oligodeoxyribonucleotides; Phenylephrine; Promoter Regions, Genetic; Protein Binding; Rats; Transcription Factors | 2002 |
Posttranscriptional control of BNP gene expression in angiotensin II-induced hypertension.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Echocardiography; Gene Expression Regulation; Heart Rate; Heart Ventricles; Hypertension; Male; Natriuretic Peptide, Brain; Organ Size; Promoter Regions, Genetic; Protein Binding; Rats; Rats, Sprague-Dawley; RNA Processing, Post-Transcriptional; RNA, Messenger; Transcription Factor AP-1 | 2002 |
Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats.
Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Corticosterone; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypertension; Imidazoles; Male; Natriuretic Peptide, Brain; Prodrugs; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Spironolactone; Stroke; Tetrazoles; Time Factors | 2002 |
Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cardiomegaly; Collagen; Fibrosis; Gene Targeting; Guanylate Cyclase; Heart Rate; Heart Ventricles; Hypertension; Imidazoles; Mice; Mice, Knockout; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Organ Size; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Atrial Natriuretic Factor; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2; Ventricular Remodeling | 2002 |
Parathyroid hormone-related protein is produced in the myocardium and increased in patients with congestive heart failure.
Topics: Adult; Angiotensin II; Aorta; Atrial Natriuretic Factor; Coronary Vessels; Diastole; Echocardiography; Endothelin-1; Female; Heart Failure; Hemodynamics; Humans; Male; Myocardium; Natriuretic Peptide, Brain; Norepinephrine; Parathyroid Hormone-Related Protein; Peptide Fragments; Protein Biosynthesis; Proteins; Stroke Volume; Systole; Ventricular Function, Left | 2002 |
Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blotting, Northern; Collagen; Diastole; Drug Therapy, Combination; Echocardiography, Doppler; Imidazoles; Male; Models, Animal; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Wistar; RNA, Messenger; Tetrazoles; Thiazepines; Ventricular Remodeling | 2003 |
Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclic GMP; Drug Interactions; Guanylate Cyclase; Male; Muscle Cells; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor | 2003 |
Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Coculture Techniques; Cyclic GMP; Cytochrome P-450 CYP11B2; Gene Expression; Myocytes, Cardiac; Natriuretic Peptide, Brain; Polysaccharides; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2003 |
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load.
Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Atrial Natriuretic Factor; Chronic Disease; Drinking; Female; Heart Failure; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuretic Peptide, Brain; Osmolar Concentration; Renin; Urine; Water-Electrolyte Balance | 2003 |
Improved neurohormonal markers of ventricular function after restoring sinus rhythm by the Maze procedure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Fibrillation; Atrial Natriuretic Factor; Chronic Disease; Cryosurgery; Female; Follow-Up Studies; Hemodynamics; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Postoperative Complications; Vasopressins; Ventricular Dysfunction, Left; Ventricular Function, Left | 2003 |
Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Hypertrophic; Fibroblast Growth Factor 1; Gene Expression Regulation; Genes, fos; Heart Rate; Hypertension; Imidazoles; Infusion Pumps, Implantable; Losartan; Male; Natriuretic Peptide, Brain; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; RNA, Messenger; Vascular Endothelial Growth Factor A | 2003 |
Endothelin-1 concentrations in pericardial fluid are more elevated in patients with ischemic heart disease than in patients with nonischemic heart disease.
Topics: Angiotensin II; Atrial Natriuretic Factor; Endothelin-1; Growth Substances; Humans; Myocardial Ischemia; Myocardium; Natriuretic Peptide, Brain; Pericardial Effusion; Prognosis; Receptors, Tumor Necrosis Factor | 2003 |
Angiotensin II-induced ventricular hypertrophy and extracellular signal-regulated kinase activation are suppressed in mice overexpressing brain natriuretic peptide in circulation.
Topics: Angiotensin II; Animals; Blood Pressure; Fibrosis; Gene Expression; Hypertrophy, Left Ventricular; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardium; Natriuretic Peptide, Brain; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-fos; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstrictor Agents | 2003 |
Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
Topics: Adrenomedullin; Angiotensin II; Angiotensinogen; Animals; Aorta, Abdominal; Cardiomegaly; Collagen Type I; Constriction; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Fibrosis; Gene Expression Regulation; Genes, fos; Genes, Lethal; Glomerulosclerosis, Focal Segmental; Heterozygote; Male; MAP Kinase Signaling System; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptides; Peptidyl-Dipeptidase A; Protein Kinase C; Proto-Oncogene Proteins c-fos; Transforming Growth Factor beta; Ventricular Remodeling | 2004 |
Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
Topics: Angiotensin II; Aquaporin 2; Aquaporins; Arginine Vasopressin; Atrial Natriuretic Factor; Case-Control Studies; Exercise; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Osmolar Concentration; Radioimmunoassay | 2004 |
Cardiac gene expression of natriuretic substances is altered in streptozotocin-induced diabetes during angiotensin II-induced pressure overload.
Topics: Adrenomedullin; Angiotensin II; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Diabetes Mellitus, Experimental; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Peptides; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Up-Regulation | 2004 |
Left ventricular reconstruction: the aim and the reality after twenty years.
Topics: Angiotensin II; Biomarkers; Cardiac Surgical Procedures; Cardiomyopathies; Heart Failure; Heart Ventricles; Humans; Myocardial Ischemia; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume; Ventricular Function, Left | 2004 |
Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy.
Topics: Aged; Angiotensin II; Biomarkers; Cardiac Surgical Procedures; Cardiomyopathies; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Renin; Statistics as Topic; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2004 |
Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Cell Division; Chemokine CCL2; Coronary Vessels; DNA-Binding Proteins; Extracellular Matrix Proteins; Gene Expression Profiling; Genetic Therapy; Hypertrophy; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-1; Interleukin-6; Macrophages; Male; Mice; Mice, Inbred C57BL; Myosin Heavy Chains; Natriuretic Peptide, Brain; Nonmuscle Myosin Type IIB; Nuclear Proteins; Olmesartan Medoxomil; Receptors, CCR2; Receptors, Chemokine; Recombinant Fusion Proteins; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Transcription Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tunica Media; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vasculitis; Ventricular Remodeling | 2004 |
Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Valve Stenosis; Apoptosis; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Disease Progression; Endoplasmic Reticulum; Gene Expression Regulation; Heart Failure; Humans; Imidazoles; Ligation; Male; Mice; Mice, Inbred C57BL; Molecular Chaperones; Myocytes, Cardiac; Natriuretic Peptide, Brain; Olmesartan Medoxomil; Rats; Rats, Inbred WKY; RNA, Messenger; Signal Transduction; Stress, Physiological; Tetrazoles; Thapsigargin; Tunicamycin | 2004 |
Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization.
Topics: Angiotensin II; Animals; Blood Volume; Dogs; Echocardiography; Heart Failure; Hemodynamics; Microcirculation; Myocardial Infarction; Natriuretic Peptide, Brain; Phosphopyruvate Hydratase; Time Factors; Ventricular Function | 2004 |
[Effect of fosinopril on the rate of neurohumoral and proinflammatory activation in patients with heart failure].
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Data Interpretation, Statistical; Echocardiography; Fosinopril; Heart Failure; Humans; Immunoenzyme Techniques; Middle Aged; Natriuretic Peptide, Brain; Radioimmunoassay; Time Factors; Tumor Necrosis Factor-alpha | 2004 |
Down-regulation of urinary AQP2 and unaffected response to hypertonic saline after 24 hours of fasting in humans.
Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Aquaporins; Atrial Natriuretic Factor; Cross-Over Studies; Down-Regulation; Fasting; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Renin; Saline Solution, Hypertonic | 2005 |
Different effects on inhibition of cardiac hypertrophy in spontaneously hypertensive rats by monotherapy and combination therapy of adrenergic receptor antagonists and/or the angiotensin II type 1 receptor blocker under comparable blood pressure reduction
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Blood Pressure; Cardiomegaly; Doxazosin; Drug Therapy, Combination; Echocardiography; Heart Rate; Hypertension; Losartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; RNA, Messenger | 2005 |
Angiotensin II, but not aldosterone and renin, correlates positively with increased concentrations of N-terminal pro-brain natriuretic peptide in patients with chronic heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Biomarkers; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Renin | 2005 |
Natriuretic peptides are negative modulators of adrenocortical cell function of the eastern fence lizard (Sceloporus undulatus).
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Cell Culture Techniques; Cells, Cultured; Chickens; Corticosterone; Eels; Female; Hormones; Lizards; Male; Mineralocorticoid Receptor Antagonists; Natriuretic Peptide, Brain; Rats | 2006 |
Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertension.
Topics: Adenoviridae; Angiotensin II; Animals; Blotting, Western; Cardiomegaly; Chemokine CCL2; Collagen Type I; Collagen Type III; Collagen Type IV; Gene Deletion; Genes, Dominant; Genetic Therapy; Genetic Vectors; Hypertension; Injections; Male; Models, Animal; Natriuretic Peptide, Brain; Phosphorylation; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Transcription Factor AP-1 | 2006 |
Scar myofibroblasts of the infarcted rat heart express natriuretic peptides.
Topics: Adrenomedullin; Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Cicatrix; Colforsin; Dose-Response Relationship, Drug; Fibroblasts; Gene Expression; Isoproterenol; Male; Myocardial Infarction; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptides; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serine Endopeptidases | 2006 |
Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Northern; Blotting, Western; Cell Hypoxia; Cells, Cultured; Collagen Type I; Collagen Type III; Electrophoretic Mobility Shift Assay; Fibroblasts; Gene Expression; Ligands; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle Cells; Myocardial Reperfusion Injury; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; Oxygen; Pioglitazone; PPAR gamma; Prostaglandin D2; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1 | 2006 |
Coronary sinus and ascending aortic levels of aldosterone, angiotensin II, and B-type natriuretic peptide in patients with aortic stenosis and in patients with coronary heart disease.
Topics: Aged; Aldosterone; Angiotensin II; Aorta; Aortic Valve Stenosis; Coronary Disease; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Procollagen; Stroke Volume; Venae Cavae | 2006 |
Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade.
Topics: Angiotensin II; Animals; Blood Pressure; Collagen; Connective Tissue Growth Factor; Diastole; Gene Expression; Heart Failure; Heart Ventricles; Hypertension; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Ion Channels; Lung; Male; Membrane Transport Proteins; Mitochondrial Proteins; Myocardium; NADPH Oxidases; Natriuretic Peptide, Brain; Organ Size; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Transforming Growth Factor beta; Uncoupling Protein 2; Ventricular Dysfunction, Left | 2006 |
Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
Topics: Aged; Aldosterone; AMP Deaminase; Angiotensin II; Atrial Natriuretic Factor; Endothelin-1; Epinephrine; Female; Genotype; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Norepinephrine; Polymorphism, Genetic; Proportional Hazards Models; Retrospective Studies | 2006 |
Pathophysiological characteristics of heart rate recovery in heart failure.
Topics: Analysis of Variance; Angiotensin II; Atrial Natriuretic Factor; Chi-Square Distribution; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Respiratory Function Tests; Risk Factors | 2006 |
Upregulated neurohumoral factors are associated with left ventricular remodeling and poor prognosis in rats with monocrotaline-induced pulmonary arterial hypertension.
Topics: Angiotensin II; Animals; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Male; Monocrotaline; Natriuretic Peptide, Brain; Norepinephrine; Prognosis; Rats; Rats, Wistar; Up-Regulation; Ventricular Remodeling | 2006 |
The effects of angiotensin-converting enzyme inhibition on the urinary excretion of NTproBNP in male volunteers.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Hematocrit; Hormones; Humans; Kidney Function Tests; Luminescence; Male; Natriuretic Peptide, Brain; Peptide Fragments; Sodium; Water-Electrolyte Balance | 2006 |
Endothelin-1 and angiotensin II contribute to BNP but not c-fos gene expression response to elevated load in isolated mice hearts.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Coronary Circulation; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Gene Expression Regulation; Genes, fos; Heart; Heart Ventricles; In Vitro Techniques; Male; Mice; Natriuretic Peptide, Brain; Receptor, Angiotensin, Type 1; Tetrazoles; Up-Regulation | 2007 |
Urocortin 1 modulates the neurohumoral response to acute nitroprusside-induced hypotension in sheep.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Corticotropin-Releasing Hormone; Cyclic GMP; Heart Rate; Hypotension; Natriuretic Peptide, Brain; Nitroprusside; Sheep; Urocortins | 2007 |
Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Interleukin-1beta; Interleukin-6; Leucine; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones | 2006 |
Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Endomyocardial Fibrosis; Female; Gene Expression Regulation; Humans; Mice; Mice, Transgenic; Muscle Proteins; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; RNA, Messenger; Signal Transduction; Vasoconstrictor Agents; Ventricular Remodeling | 2007 |
B-Type natriuretic peptide inhibited angiotensin II-stimulated cholesterol biosynthesis, cholesterol transfer, and steroidogenesis in primary human adrenocortical cells.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Angiotensin II; Cell Line, Tumor; Cells, Cultured; Cholesterol; Cyclic GMP; Drug Interactions; Gene Expression Profiling; Gene Expression Regulation; Humans; Lipoproteins; Male; Middle Aged; Natriuretic Peptide, Brain; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Steroids; Vasoconstrictor Agents | 2007 |
Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Cell Proliferation; Cell Size; Cells, Cultured; Cyclic GMP; Fibroblasts; Intracellular Space; L-Lactate Dehydrogenase; Male; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes | 2007 |
Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Predictive Value of Tests; Prognosis; Renin; Retrospective Studies; Survival Rate; Ventricular Function, Left | 2007 |
Cardiac BNP gene activation by angiotensin II in vivo.
Topics: Angiotensin II; Animals; Body Weight; Cells, Cultured; DNA; GATA4 Transcription Factor; GATA6 Transcription Factor; Gene Expression Regulation; Hypertension; Hypertrophy, Left Ventricular; Male; Mice; Mice, Transgenic; Myocardium; Natriuretic Peptide, Brain; Organ Size; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-ets; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; RNA, Messenger; Transcription Factor AP-1; Transcriptional Activation | 2007 |
Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes.
Topics: Age Factors; Angiotensin II; Animals; Calcium; Calcium Signaling; Cardiomegaly; Cells, Cultured; Chromogranin B; Inositol 1,4,5-Trisphosphate Receptors; Myocytes, Cardiac; Natriuretic Peptide, Brain; NF-kappa B; NFATC Transcription Factors; Promoter Regions, Genetic; Rats; Transcription, Genetic; Vasoconstrictor Agents | 2008 |
Cellular physiology of rat cardiac myocytes in cardiac fibrosis: in vitro simulation using the cardiac myocyte/cardiac non-myocyte co-culture system.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cell Separation; Cells, Cultured; Coculture Techniques; Diuretics, Osmotic; Endothelin-1; Fibrosis; Leucine; Mannitol; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptors, Angiotensin; Renin; Thymidine; Transforming Growth Factor beta1; Tritium | 2008 |
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension.
Topics: Administration, Oral; Amino Acid Sequence; Angiotensin II; Animals; Dogs; Drug Administration Schedule; Hypertension; Male; Molecular Sequence Data; Natriuretic Peptide, Brain; Random Allocation | 2008 |
Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats.
Topics: Angiotensin II; Animals; Collagen; Male; Myocardial Infarction; Natriuretic Agents; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley; RNA, Messenger; Smad2 Protein; Time Factors; Transforming Growth Factor beta1; Treatment Outcome; Ventricular Remodeling | 2009 |
NPRA-mediated suppression of AngII-induced ROS production contribute to the antiproliferative effects of B-type natriuretic peptide in VSMC.
Topics: Angiotensin II; Animals; Aorta; Cell Proliferation; Cells, Cultured; Cyclic GMP; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Natriuretic Peptide, Brain; Rats; Reactive Oxygen Species; Receptors, Atrial Natriuretic Factor; RNA, Small Interfering | 2009 |
Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
Topics: Acyl-CoA Dehydrogenase; Angiotensin II; Animals; Carnitine O-Palmitoyltransferase; Cells, Cultured; Fatty Acids; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; NF-kappa B; Oxidation-Reduction; PPAR alpha; PPAR delta; PPAR gamma; PPAR-beta; Rats; Rats, Inbred Strains; Reactive Oxygen Species; Signal Transduction; Tumor Necrosis Factor-alpha | 2009 |
Characterization of promoter elements required for cardiac chamber-specific expression.
Topics: Angiotensin II; Animals; Base Sequence; Binding Sites; Electrophoretic Mobility Shift Assay; Endothelin-1; Fish Proteins; GATA Transcription Factors; Gene Expression Regulation; Heart Ventricles; Molecular Sequence Data; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Natriuretic Peptides; Organ Specificity; Promoter Regions, Genetic; Protein Binding; Rats; Stress, Mechanical; Transcription Factor AP-1; Transcription Initiation Site | 2009 |
[Influence of chronic cardiac failure severity on the course of comorbid type 2 diabetes mellitus].
Topics: Aged; Angiotensin II; C-Peptide; Comorbidity; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Insulin; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Retrospective Studies; Severity of Illness Index | 2009 |
Cardiac phenotype and angiotensin II levels in AT1a, AT1b, and AT2 receptor single, double, and triple knockouts.
Topics: Angiotensin II; Animals; Atrophy; Coronary Circulation; Fibrosis; Genotype; Kidney; Male; Mice; Mice, Knockout; Myocardium; Natriuretic Peptide, Brain; Perfusion; Phenotype; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2010 |
Hormone-dependent dissociation of blood flow and secretion rate in the lingual salt glands of the estuarine crocodile, Crocodylus porosus.
Topics: Alligators and Crocodiles; Angiotensin II; Animals; Blood Pressure; Heart Rate; Natriuretic Peptide, Brain; Regional Blood Flow; Salt Gland; Vasoactive Intestinal Peptide; Water-Electrolyte Balance | 2010 |
Effect of intermedin1-53 on angiotensin II-induced hypertrophy in neonatal rat ventricular myocytes.
Topics: Adrenomedullin; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Heart Ventricles; Myocytes, Cardiac; Natriuretic Peptide, Brain; Neuropeptides; Rats; Rats, Wistar; RNA, Messenger | 2010 |
Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
Topics: Angiotensin II; Animals; Antibodies; Atrial Natriuretic Factor; Cell Enlargement; Cell Line, Transformed; Cell Proliferation; Cell Survival; Curcumin; Gene Expression; Losartan; Membrane Glycoproteins; Mice; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidases; Natriuretic Peptide, Brain; NF-kappa B; Oxidative Stress; Protein Subunits; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Scavenger Receptors, Class E; Signal Transduction; Transfection | 2010 |
Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression.
Topics: Angiotensin II; Animals; Cells, Cultured; Endothelin-1; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Male; Mice; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nuclear Proteins; Promoter Regions, Genetic; Protein Transport; Rats; Serum Response Factor; Stress, Mechanical; Trans-Activators | 2010 |
Reduced baroreflex sensitivity and pulmonary dysfunction in alcoholic cirrhosis: effect of hyperoxia.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Baroreflex; Case-Control Studies; Endothelin-1; Female; Humans; Hyperoxia; Liver Cirrhosis, Alcoholic; Lung Diseases; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Oxygen; Renin | 2010 |
Stretch-induced hypertrophy of isolated adult rabbit cardiomyocytes.
Topics: Angiotensin II; Animals; Cell Enlargement; Cell Size; Cells, Cultured; Culture Media, Conditioned; Insulin-Like Growth Factor I; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stress, Mechanical; Transforming Growth Factor beta | 2010 |
Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.
Topics: Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Echocardiography; Fibrosis; Heart Atria; Heparin Cofactor II; Mice; Mice, Transgenic; Myocardium; Natriuretic Peptide, Brain; Oxidative Stress; Transforming Growth Factor beta1; Ventricular Remodeling | 2010 |
Collagen XV is necessary for modeling of the extracellular matrix and its deficiency predisposes to cardiomyopathy.
Topics: Age Factors; Aging; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomyopathies; Collagen; Coronary Circulation; Disease Models, Animal; Echocardiography; Elasticity; Enzyme Inhibitors; Extracellular Matrix; Female; Gene Expression Profiling; Gene Expression Regulation; Genotype; Heart Ventricles; Hemodynamics; Hypertension; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Microscopy, Electron; Microscopy, Video; Myocardium; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenotype; Polymerase Chain Reaction; RNA, Messenger; Telemetry; Ventricular Remodeling | 2010 |
Amlodipine suppressed cardiac gene expression of brain natriuretic peptide, transforming growth factor-β₁ and fibronectin mediated by aldosterone in male stroke-prone spontaneously hypertensive rats.
Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Fibronectins; Gene Expression Regulation; Heart; Hypertension; Male; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Transforming Growth Factor beta | 2010 |
Therapeutic effects of continuous infusion of brain natriuretic peptides on postmyocardial infarction ventricular remodelling in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Collagen; Cyclic GMP; Disease Models, Animal; Enalapril; Hemodynamics; I-kappa B Proteins; Inflammation Mediators; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Phosphorylation; Rats; Rats, Sprague-Dawley; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor RelA; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Cardiotonic Agents; Disease Models, Animal; Down-Regulation; Flavonoids; Heart Failure; Hemodynamics; Isoproterenol; Male; Matrix Metalloproteinases; Mitochondria; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Norepinephrine; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2011 |
Improved cardiac function after sarcoplasmic reticulum Ca(2+)-ATPase gene transfer in a heart failure model induced by chronic myocardial ischaemia.
Topics: Adenoviridae; Angiotensin II; Animals; Disease Models, Animal; Endothelin-1; Fluorescent Dyes; Gene Transfer Techniques; Genetic Therapy; Green Fluorescent Proteins; Heart Failure; Interleukin-6; Male; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Stroke Volume; Swine; Swine, Miniature; Tumor Necrosis Factor-alpha | 2011 |
Intramyocardial BNP gene delivery improves cardiac function through distinct context-dependent mechanisms.
Topics: Adenoviridae; Angiotensin II; Animals; Collagen Type III; Disease Models, Animal; Fibrosis; Gene Transfer Techniques; Genetic Therapy; Humans; Hypertension; Ligation; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Neovascularization, Physiologic; Organothiophosphorus Compounds; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |
Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Topics: Adiponectin; AMP-Activated Protein Kinases; Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Genes, Reporter; Hydrogen Peroxide; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; NF-kappa B; Oxidants; Oxidative Stress; Phosphorylation; Rats; Reactive Oxygen Species; Recombinant Proteins; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Ventricular Remodeling | 2011 |
Angiotensin II type-1 receptor-JAK/STAT pathway mediates the induction of visfatin in angiotensin II-induced cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Hypertrophy; Janus Kinases; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nicotinamide Phosphoribosyltransferase; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; STAT Transcription Factors | 2012 |
Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium; Cardiotonic Agents; Cell Line; Collagen; Cyclopentanes; Echocardiography, Doppler; Estrogens; Female; Gene Expression Regulation; Genotype; Hypertrophy, Left Ventricular; Injections, Subcutaneous; Mice; Myocytes, Cardiac; NADPH Oxidase 4; NADPH Oxidases; Natriuretic Peptide, Brain; Ovariectomy; Phenotype; Quinolines; Rats; Rats, Inbred Lew; Rats, Transgenic; Receptors, G-Protein-Coupled; Renin; RNA, Messenger; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2012 |
Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.
Topics: Angiotensin II; Animals; Cardiomegaly; Cell Adhesion Molecules; Cyclic GMP; Endothelin-1; Guanylate Cyclase; Microfilament Proteins; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; Nitrites; Nitrogen Oxides; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Phosphorylation; Rats; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Superoxides | 2012 |
[Hypertension-induced fibrosis: a balance story].
Topics: Aldosterone; Angiotensin II; Animals; Bone Morphogenetic Proteins; Cardiomegaly; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertension; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Natriuretic Peptide, Brain; Renin; Renin-Angiotensin System | 2012 |
Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Collagen; Gene Expression Regulation; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Kidney; Losartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stroke Volume; Transforming Growth Factor beta1; Ultrasonography | 2012 |
Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
Topics: Alendronate; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Contraindications; Fibrosis; Gene Expression Regulation; Geranyltranstransferase; Humans; Male; Mice; Myocytes, Cardiac; Natriuretic Peptide, Brain; p38 Mitogen-Activated Protein Kinases; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Signal Transduction; Terpenes; Transforming Growth Factor beta1 | 2013 |
Metastasis-associated protein, S100A4 mediates cardiac fibrosis potentially through the modulation of p53 in cardiac fibroblasts.
Topics: Angiotensin II; Animals; Cell Proliferation; Collagen; Connective Tissue Growth Factor; Fibrosis; Gene Expression Regulation; Gene Knockout Techniques; Heart Failure; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Mice; Mice, Knockout; Myofibroblasts; Natriuretic Peptide, Brain; NIH 3T3 Cells; Rats; Rats, Inbred Dahl; S100 Calcium-Binding Protein A4; S100 Proteins; Transcriptome; Tumor Suppressor Protein p53 | 2013 |
Possible correlation among echocardiographic measures, serum brain natriuretic peptide, and angiotensin II levels in hypertensive kidney transplanted children.
Topics: Adolescent; Angiotensin II; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Child; Child, Preschool; Circadian Rhythm; Cross-Sectional Studies; Echocardiography; Female; Humans; Hypertension, Renal; Hypertrophy, Left Ventricular; Kidney Transplantation; Male; Models, Cardiovascular; Natriuretic Peptide, Brain; Postoperative Complications; Risk Factors | 2013 |
MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
Topics: Angiotensin II; Animals; Anticholesteremic Agents; Atorvastatin; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Down-Regulation; Heptanoic Acids; Male; Mice; MicroRNAs; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Oligonucleotides, Antisense; Phosphoric Monoester Hydrolases; PTEN Phosphohydrolase; Pyrroles; Rats | 2013 |
Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 cells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiotonic Agents; Cell Line; Cell Size; Collagen; Gene Expression; Hypertrophy, Left Ventricular; Male; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; PPAR gamma; Quercetin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Transcription Factor AP-1 | 2013 |
B-type natriuretic peptide inhibits angiotensin II-induced proliferation and migration of pulmonary arterial smooth muscle cells.
Topics: Angiotensin II; Animals; Calcium; Cell Movement; Cell Proliferation; Cells, Cultured; Down-Regulation; MAP Kinase Signaling System; Mitochondria; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Natriuretic Agents; Natriuretic Peptide, Brain; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Rats; Rats, Wistar; Reactive Oxygen Species; Vasoconstrictor Agents | 2014 |
Serum levels of renin-angiotensin system components in acute stroke patients.
Topics: Acute Disease; Aged; Angiotensin II; Angiotensin-Converting Enzyme 2; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Male; Natriuretic Peptide, Brain; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Retrospective Studies; Severity of Illness Index; Stroke | 2014 |
Pitavastatin-attenuated cardiac dysfunction in mice with dilated cardiomyopathy via regulation of myocardial calcium handling proteins.
Topics: Angiotensin II; Animals; Calcium; Cardiomyopathy, Dilated; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Protein Kinase C beta; Quinolines; Random Allocation; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2014 |
A comparison of the efficacy of surgical renal denervation and pharmacologic therapies in post-myocardial infarction heart failure.
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Denervation; Disease Models, Animal; Endothelins; Heart Failure; Heart Rate; Hemodynamics; Kidney; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Norepinephrine; Rats; Rats, Wistar; Renin; Treatment Outcome; Ventricular Function, Left | 2014 |
Renal sympathetic denervation suppresses ventricular substrate remodelling in a canine high-rate pacing model.
Topics: Aldosterone; Angiotensin II; Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Catheter Ablation; Disease Models, Animal; Disease Progression; Dogs; Female; Fibrosis; Heart Failure; Heart Ventricles; Kidney; Male; Natriuretic Peptide, Brain; Sympathectomy; Time Factors; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2014 |
Overexpression of PEP-19 suppresses angiotensin II-induced cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium; Calcium Signaling; Calcium-Binding Proteins; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calmodulin; Calmodulin-Binding Proteins; Cardiomegaly; Cells, Cultured; Gene Expression; Hypertrophy; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats, Sprague-Dawley; Sarcoplasmic Reticulum | 2014 |
Elimination of vitamin D receptor in vascular endothelial cells alters vascular function.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blood Pressure; Blotting, Western; Disease Models, Animal; DNA; Endothelial Cells; Endothelium, Vascular; Gene Expression Regulation; Humans; Hypertension; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Natriuretic Peptide, Brain; Rats; Receptors, Calcitriol; Vasodilation | 2014 |
An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
Topics: Adenosine A1 Receptor Agonists; Angiotensin II; Animals; Calcineurin; Cyclosporine; Enzyme Inhibitors; In Vitro Techniques; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Rats; RNA, Messenger; Signal Transduction | 2014 |
Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling.
Topics: Active Transport, Cell Nucleus; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cell Nucleus; Cells, Cultured; Histone Deacetylase 2; Hydroxamic Acids; Janus Kinase 2; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments; Pressure; Rats; Signal Transduction; Tyrphostins | 2014 |
Protective effects of valsartan and benazepril combined with atorvastatin on cardiorenal syndrome in rats.
Topics: Angiotensin II; Animals; Atorvastatin; Benzazepines; C-Reactive Protein; Cardio-Renal Syndrome; Case-Control Studies; Drug Synergism; Heptanoic Acids; Lipids; Male; Natriuretic Peptide, Brain; Proteinuria; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2015 |
3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Cell Line; Gene Expression Regulation; Indoles; Models, Biological; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Phosphorylation; Rats; Signal Transduction; TOR Serine-Threonine Kinases; Vasoconstrictor Agents | 2015 |
Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Hypertension, Renovascular; Natriuretic Peptide, Brain; Nitrobenzenes; Rats; Sulfonamides | 2015 |
Endogenous BNP attenuates cardiomyocyte hypertrophy induced by Ang II via p38 MAPK/Smad signaling.
Topics: Angiotensin II; Animals; Animals, Newborn; Cell Size; Cells, Cultured; Leucine; Myocytes, Cardiac; Natriuretic Peptide, Brain; p38 Mitogen-Activated Protein Kinases; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins, Receptor-Regulated | 2014 |
[Renal sympathetic denervation suppresses ventricular substrate remodeling in a canine high-rate pacing model].
Topics: Aldosterone; Angiotensin II; Animals; Cardiac Pacing, Artificial; Dogs; Enzyme-Linked Immunosorbent Assay; Heart Failure; Heart Ventricles; Hemodynamics; Models, Animal; Natriuretic Peptide, Brain; Sympathectomy; Ventricular Remodeling | 2015 |
[Qangxin Granule Intervened Chronic Heart Failure Rats with Xin-qi Deficiency Complicated Blood Stasis and Edema Syndrome: an Experimental Study].
Topics: Angiotensin II; Animals; C-Reactive Protein; Chronic Disease; Drugs, Chinese Herbal; Edema; Heart; Heart Failure; Heart Ventricles; Medicine, Chinese Traditional; Natriuretic Peptide, Brain; Qi; Rats; Rats, Sprague-Dawley; Syndrome; Thyrotropin; Ventricular Function, Left | 2015 |
Inhibition of Mitochondrial Complex-1 Prevents the Downregulation of NKCC2 and ENaCα in Obstructive Kidney Disease.
Topics: Angiotensin II; Animals; Dinoprostone; Electron Transport Complex I; Epithelial Sodium Channels; Gene Expression Regulation; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mitochondria; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase Type II; Rotenone; Signal Transduction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Solute Carrier Family 12, Member 1; Solute Carrier Family 12, Member 3; Ureteral Obstruction | 2015 |
Serum apelin is associated with left ventricular hypertrophy in untreated hypertension patients.
Topics: Adult; Angiotensin II; Animals; Apelin; Apelin Receptors; Blood Pressure; C-Reactive Protein; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Intercellular Signaling Peptides and Proteins; Ligands; Male; Middle Aged; Myocytes, Cardiac; Natriuretic Peptide, Brain; Prevalence; Rats; Receptors, G-Protein-Coupled; ROC Curve; Transfection | 2015 |
Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
Topics: Angiotensin II; Animals; Animals, Newborn; Aspirin; Atrial Natriuretic Factor; Calcineurin; Calcium; Calcium Signaling; Cardiovascular Agents; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Mice; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; NFATC Transcription Factors; Phosphorylation; Stroke Volume; Ventricular Function, Left | 2016 |
Long-Term Structural and Functional Myocardial Adaptations in Healthy Living Kidney Donors: A Pilot Study.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Cross-Sectional Studies; Female; Heart; Humans; Kidney Transplantation; Living Donors; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Pilot Projects; Procollagen | 2015 |
Renal Denervation Findings on Cardiac and Renal Fibrosis in Rats with Isoproterenol Induced Cardiomyopathy.
Topics: Angiotensin II; Animals; Biomarkers; Cardiomyopathies; Cytokines; Denervation; Fibrosis; Heart Atria; Heart Ventricles; Inflammation Mediators; Isoproterenol; Kidney; Kidney Diseases; Male; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Procollagen; Rats, Sprague-Dawley; Renin-Angiotensin System | 2015 |
Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; DNA, Mitochondrial; Electron Transport Complex I; Electron Transport Complex II; Enzyme Inhibitors; Gene Expression; Heart; Heart Failure; Hydrogen Peroxide; Mice; Mitochondria, Heart; Myocardium; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Protein Precursors; Pyruvate Dehydrogenase Complex; Reverse Transcriptase Polymerase Chain Reaction; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Vasoconstrictor Agents | 2016 |
Interleukin-10 deficiency aggravates angiotensin II-induced cardiac remodeling in mice.
Topics: Angiotensin II; Animals; Cardiomegaly; Collagen; Interleukin-10; Interleukin-6; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Natriuretic Peptide, Brain; Oncogene Protein v-akt; Ultrasonography; Ventricular Remodeling | 2016 |
Renal denervation significantly attenuates cardiorenal fibrosis in rats with sustained pressure overload.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart Atria; Heart Ventricles; Humans; Kidney; Losartan; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Procollagen; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sympathectomy | 2016 |
Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models.
Topics: Angiotensin II; Animals; Apolipoproteins E; Cardiomegaly; Cell Line; Fibrosis; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Transforming Growth Factor beta1 | 2016 |
Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathy.
Topics: Alanine Transaminase; Angiotensin II; Animals; Aorta; Blood Pressure; Carbazoles; Cardiomegaly; Cardiomyopathies; Carvedilol; Constriction; Cystatin C; Denervation; Fibrosis; Heart Rate; Kidney; Malondialdehyde; Natriuretic Peptide, Brain; Organ Specificity; Oxidative Stress; Peptide Fragments; Procollagen; Propanolamines; Rats, Sprague-Dawley; Superoxide Dismutase; Transforming Growth Factor beta1; Vascular Remodeling | 2016 |
Let-7a Is an Antihypertrophic Regulator in the Heart via Targeting Calmodulin.
Topics: 3' Untranslated Regions; Angiotensin II; Animals; Atrial Natriuretic Factor; Calmodulin; Cardiomegaly; Cells, Cultured; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2017 |
Effects of the Activin A-Follistatin System on Myocardial Cell Apoptosis through the Endoplasmic Reticulum Stress Pathway in Heart Failure.
Topics: Activins; Angiotensin II; Animals; Apoptosis; Biomarkers; Caspase 3; Cell Line; Disease Models, Animal; Endoplasmic Reticulum Stress; Female; Follistatin; Heart Failure; Heart Ventricles; Hemodynamics; Immunohistochemistry; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Signal Transduction; Transcription Factor CHOP | 2017 |
Role of microRNA-124 in cardiomyocyte hypertrophy inducedby angiotensin II.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calreticulin; Cardiomegaly; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Expression Regulation; Heat-Shock Proteins; Humans; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Ventricular Myosins | 2017 |
Positive correlation between blood pressure or heart rate and chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes measured by new ELISA.
Topics: Adult; Age Factors; Aged; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Chymases; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Heart Rate; Humans; Hypertension; Leukocytes, Mononuclear; Male; Middle Aged; Natriuretic Peptide, Brain; Sex Factors | 2018 |
VEGFB-VEGFR1 ameliorates Ang II-induced cardiomyocyte hypertrophy through Ca
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cell Line; Cell Size; Cyclic GMP-Dependent Protein Kinase Type I; Gene Knockdown Techniques; Hypertrophy; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Rats; Signal Transduction; Vascular Endothelial Growth Factor B; Vascular Endothelial Growth Factor Receptor-1 | 2018 |
Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Cells, Cultured; Dihydropyridines; Gene Expression Regulation; Histone Deacetylases; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; Rats; Signal Transduction | 2017 |
Stimulation of ganglionated plexus attenuates cardiac neural remodeling and heart failure progression in a canine model of acute heart failure post-myocardial infarction.
Topics: Angiotensin II; Animals; Biomarkers; Disease Models, Animal; Disease Progression; Dogs; Electric Stimulation Therapy; GAP-43 Protein; Heart; Heart Failure; Male; Myocardial Infarction; Natriuretic Peptide, Brain; Nerve Growth Factor; Norepinephrine; Parasympathetic Nervous System; Proto-Oncogene Proteins c-fos; Random Allocation; Tyrosine 3-Monooxygenase | 2017 |
Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cell Survival; Cells, Cultured; Collagen Type I; Collagen Type II; Echocardiography; Fibroblasts; Fibrosis; Heart Ventricles; Human Umbilical Vein Endothelial Cells; Humans; Kaempferols; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Signal Transduction; Transforming Growth Factor beta1; Ventricular Remodeling | 2017 |
Gallic acid attenuates calcium calmodulin-dependent kinase II-induced apoptosis in spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Atrial Natriuretic Factor; bcl-2-Associated X Protein; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiotonic Agents; Caspase 3; Cell Line; Gallic Acid; Gene Expression Regulation; Hypertension; Hypertrophy, Left Ventricular; Isoenzymes; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitric Oxide Synthase; p300-CBP Transcription Factors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Tumor Suppressor Protein p53 | 2018 |
[Over-expression of BDNF inhibits angiotensin II-induced apoptosis of cardiomyocytes in SD rats].
Topics: Angiotensin II; Animals; Apoptosis; Atrial Natriuretic Factor; Brain-Derived Neurotrophic Factor; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cells, Cultured; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Overexpression of SARAF Ameliorates Pressure Overload-Induced Cardiac Hypertrophy Through Suppressing STIM1-Orai1 in Mice.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Atrial Natriuretic Factor; Cardiomegaly; Cell Line; Echocardiography; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; ORAI1 Protein; Pressure; Stromal Interaction Molecule 1; Up-Regulation; Ventricular Function, Left | 2018 |
Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling.
Topics: Albuminuria; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Cardio-Renal Syndrome; Creatinine; Cystatin C; Drugs, Chinese Herbal; Interleukin-6; Kidney; Male; Myocardial Infarction; NADPH Oxidase 2; Natriuretic Peptide, Brain; Oxidative Stress; Phytotherapy; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Signal Transduction; Tumor Necrosis Factor-alpha | 2018 |
The Effects of Dracocephalum Heterophyllum Benth Flavonoid on Hypertrophic Cardiomyocytes Induced by Angiotensin II in Rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cells, Cultured; China; Flavonoids; Heart Ventricles; Medicine, Tibetan Traditional; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Bakuchiol protects against pathological cardiac hypertrophy by blocking NF-κB signaling pathway.
Topics: Administration, Oral; Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Collagen; Connective Tissue Growth Factor; Constriction, Pathologic; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; NF-kappa B; Phenols; Plant Extracts; Primary Cell Culture; Psoralea; Signal Transduction | 2018 |
Clinical significance of increased urotensin II levels in acute myocardial infarction.
Topics: Angiotensin II; Animals; Animals, Newborn; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Phosphorylation; Predictive Value of Tests; Rats, Wistar; Sensitivity and Specificity; Stroke Volume; Up-Regulation; Urotensins | 2018 |
Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
Topics: Angiotensin II; Animals; Apoptosis; Atrial Natriuretic Factor; Cardiomegaly; Carrier Proteins; Cells, Cultured; Heart Failure; Intracellular Signaling Peptides and Proteins; Male; MicroRNAs; Mitochondria, Heart; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley | 2018 |
MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Topics: Angiotensin II; Animals; Aorta; Cardiomegaly; Disease Models, Animal; Gene Expression Regulation; Gene Knockdown Techniques; Heart Failure; Humans; Isoenzymes; L-Lactate Dehydrogenase; MicroRNAs; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Primary Cell Culture; Rats; Signal Transduction | 2019 |
GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Bone Morphogenetic Proteins; Cardiomegaly; Chemokine CCL11; Down-Regulation; Growth Differentiation Factors; Mice; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain | 2018 |
Epigallocatechin-3-gallate inhibits angiotensin II-induced cardiomyocyte hypertrophy via regulating Hippo signaling pathway in H9c2 rat cardiomyocytes.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Catechin; Cell Line; Gene Expression Regulation; Molecular Structure; Myocytes, Cardiac; Natriuretic Peptide, Brain; Protein Serine-Threonine Kinases; Rats; Reactive Oxygen Species; Signal Transduction | 2019 |
High Fib4 index in patients with suspected NASH is associated with elevation of chymase-dependent angiotensin II-forming activity in circulating mononuclear leucocytes.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Biomarkers; Blood Pressure; Chymases; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Natriuretic Peptide, Brain; Non-alcoholic Fatty Liver Disease; Pulse Wave Analysis; Regression Analysis | 2019 |
The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation.
Topics: Aged; Aged, 80 and over; Angiotensin II; Animals; Autophagy; Autophagy-Related Protein 5; Cardiomegaly; Case-Control Studies; Catalytic Domain; Female; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Proteasome Endopeptidase Complex; Rats; RNA Interference; RNA, Small Interfering; Up-Regulation | 2019 |
[Aconitine ameliorates cardiomyocyte hypertrophy induced by angiotensin Ⅱ].
Topics: Aconitine; Actins; Angiotensin II; Atrial Natriuretic Factor; Cardiac Myosins; Cardiomegaly; Cells, Cultured; Humans; Hypertrophy; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain | 2019 |
Assessment of Pregabalin-Induced Cardiotoxicity in Rats: Mechanistic Role of Angiotensin 1-7.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Cardiotoxicity; Cyclic AMP-Dependent Protein Kinases; Heart Diseases; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinase; Pregabalin; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Stroke Volume; Ventricular Function, Left | 2020 |
Inhibition of microRNA-146a attenuated heart failure in myocardial infarction rats.
Topics: Angiotensin II; Animals; Animals, Newborn; Antagomirs; Atrial Remodeling; Disease Models, Animal; Heart; Heart Failure; Humans; MicroRNAs; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.
Topics: Acyl-CoA Dehydrogenase; Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Autophagy; Beclin-1; Cardiomegaly; Cells, Cultured; Energy Metabolism; Female; Gene Silencing; Male; Microtubule-Associated Proteins; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pyruvate Kinase; Rats, Sprague-Dawley; Resveratrol; Sirtuins | 2020 |
Ndufs1 Deficiency Aggravates the Mitochondrial Membrane Potential Dysfunction in Pressure Overload-Induced Myocardial Hypertrophy.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Biomarkers; Cardiomegaly; Constriction, Pathologic; Down-Regulation; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; NADH Dehydrogenase; Natriuretic Peptide, Brain; Pressure; Rats; RNA-Seq; Single-Cell Analysis | 2021 |
Serum microRNA-30d is a sensitive biomarker for angiotensin II-induced cardiovascular complications in rats.
Topics: Angiotensin II; Animals; Biomarkers; Cardiomegaly; Hypertension; MicroRNAs; Myocytes, Cardiac; Natriuretic Peptide, Brain; Rats | 2021 |
Targeting of midkine alleviates cardiac hypertrophy via attenuation of oxidative stress and autophagy.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Autophagy; Cardiomegaly; Mice; Midkine; Myocytes, Cardiac; Natriuretic Peptide, Brain; Oxidative Stress | 2022 |
Circ-TLR4 promotes cardiac hypertrophy through recruiting FUS to stabilize TLR4 mRNA.
Topics: Angiotensin II; Atrial Natriuretic Factor; Cardiomegaly; Humans; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; RNA-Binding Protein FUS; RNA, Circular; RNA, Messenger; Toll-Like Receptor 4 | 2022 |
Vaspin Ameliorates Cardiac Remodeling by Suppressing Phosphoinositide 3-Kinase/Protein Kinase B Pathway to Improve Oxidative Stress in Heart Failure Rats.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Collagen; Fibrosis; Heart Failure; Myocardial Infarction; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; Oxidative Stress; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Ventricular Remodeling | 2022 |
G-protein coupled receptor 30 attenuates myocardial hypertrophy by reducing oxidative stress and apoptosis in Ang II-treated mice.
Topics: Angiotensin II; Animals; Apoptosis; Atrial Natriuretic Factor; Cardiomegaly; Female; Fibrosis; GTP-Binding Proteins; Mice; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptide, Brain; Oxidative Stress; Peptide Hormones; Rats; Receptors, Estrogen; Receptors, G-Protein-Coupled | 2022 |
Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Guanylate Cyclase; Humans; Natriuretic Peptide, Brain; Natriuretic Peptides; Rats; Receptors, Atrial Natriuretic Factor | 2023 |